RGD DISEASE ONTOLOGY - ANNOTATIONS |
|
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
|
Term: | obesity |
|
Accession: | DOID:9970
|
browse the term
|
Definition: | An overnutrition that is characterized by excess body fat, traditionally defined as an elevated ratio of weight to height (specifically 30 kilograms per meter squared), has_material_basis_in a multifactorial etiology related to excess nutrition intake, decreased caloric utilization, and genetic susceptibility, and possibly medications and certain disorders of metabolism, endocrine function, and mental illness. (DO) |
Synonyms: | narrow_synonym: | MONOGENIC NON-SYNDROMIC OBESITY; Maternal Obesity; OBESITY DUE TO SIM1 DEFICIENCY; OBESITY, MILD, EARLY-ONSET; Obesity, Late-Onset; Obesity, autosomal dominant; severe obesity and type II diabetes |
| related_synonym: | ADIPQTL2; ADIPQTL3; BMIQ1; BMIQ10; BMIQ11; BMIQ12; BMIQ14; BMIQ18; BMIQ4; BMIQ7; BMIQ8; BMIQ9; Body Mass Index Quantitative Trait Locus 1; Body Mass Index Quantitative Trait Locus 10; Body Mass Index Quantitative Trait Locus 11; Body Mass Index Quantitative Trait Locus 12; Body Mass Index Quantitative Trait Locus 14; Body Mass Index Quantitative Trait Locus 18; Body Mass Index Quantitative Trait Locus 19; Body Mass Index Quantitative Trait Locus 4; Body Mass Index Quantitative Trait Locus 7; Body Mass Index Quantitative Trait Locus 8; Body Mass Index Quantitative Trait Locus 9; CAQ14; CAQ5; CIRCULATING ADIPONECTIN QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 14; CIRCULATING ADIPONECTIN QUANTITATIVE TRAIT LOCUS ON CHROMOSOME 5; LEANNESS; MELANOCORTIN 4 RECEPTOR POLYMORPHISM; OBESITY, AGE AT ONSET OF; OBESITY, ASSOCIATION WITH; OBESITY, EARLY-ONSET, SUSCEPTIBILITY TO; OBESITY, RESISTANCE TO; UCP3 polymorphism G/A; obesity, variation in; serum level of adiponectin, quantitative trait locus 2; serum level of adiponectin, quantitative trait locus 3 |
| primary_id: | MESH:D009765 |
| alt_id: | MESH:D000079262; OMIM:300306; OMIM:601665; OMIM:602025; OMIM:603188; OMIM:606641; OMIM:606770; OMIM:606771; OMIM:607447; OMIM:607514; OMIM:608410; OMIM:612459; OMIM:612460; OMIM:615457 |
| xref: | ICD10CM:E66.9; ICD9CM:278.00; NCI:C159658; NCI:C3283 |
For additional species annotation, visit the
Alliance of Genome Resources.
|
|
|
|
G |
Aacs |
acetoacetyl-CoA synthetase |
|
IEP |
mRNA:altered expression:thalamus, hypothalamus (rat) |
RGD |
PMID:19219059 |
RGD:2326191 |
NCBI chr12:36,512,393...36,555,694
Ensembl chr12:36,512,393...36,555,694
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
susceptibility disease_progression |
ISO IEP |
DNA:SNP:exon:p.R230C (rs9282541) (human) mRNA:increased expression:liver (rat) |
RGD |
PMID:17287470, PMID:25612518 |
RGD:1601092, RGD:15045599 |
NCBI chr 5:69,857,717...69,983,042
Ensembl chr 5:69,857,771...69,983,015
|
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
|
ISO |
|
RGD |
PMID:21726512 |
RGD:14688050 |
NCBI chr 3:55,480,024...55,587,946
Ensembl chr 3:55,480,024...55,587,946
|
|
G |
Abcg5 |
ATP binding cassette subfamily G member 5 |
disease_progression |
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:25612518 |
RGD:15045599 |
NCBI chr 6:7,935,771...7,961,207
Ensembl chr 6:7,935,771...7,961,207
|
|
G |
Abcg8 |
ATP binding cassette subfamily G member 8 |
|
ISO |
|
RGD |
PMID:15331430 |
RGD:1601095 |
NCBI chr 6:7,961,413...7,980,708
Ensembl chr 6:7,961,413...7,980,708
|
|
G |
Acacb |
acetyl-CoA carboxylase beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr12:48,127,149...48,238,969
Ensembl chr12:48,127,149...48,238,887
|
|
G |
Acadm |
acyl-CoA dehydrogenase medium chain |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 2:260,124,418...260,148,589
Ensembl chr 2:260,124,418...260,148,589
|
|
G |
Ace |
angiotensin I converting enzyme |
no_association |
IEP ISO |
protein:increased expression:liver |
RGD |
PMID:19361967, PMID:17164796 |
RGD:2325227, RGD:1601115 |
NCBI chr10:94,170,766...94,213,831
Ensembl chr10:94,170,766...94,187,822
|
|
G |
Ache |
acetylcholinesterase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29273807 |
|
NCBI chr12:22,472,358...22,477,052
Ensembl chr12:22,472,358...22,478,753
|
|
G |
Acly |
ATP citrate lyase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr10:88,392,248...88,442,845
Ensembl chr10:88,392,248...88,442,845
|
|
G |
Acp1 |
acid phosphatase 1 |
severity |
ISO |
associated with Diabetes Mellitus, Non-Insulin-Dependent |
RGD |
PMID:2373509, PMID:9198310 |
RGD:1625289, RGD:2313187 |
NCBI chr 6:49,836,064...49,851,714
Ensembl chr 6:49,836,075...49,851,714
|
|
G |
Acp5 |
acid phosphatase 5, tartrate resistant |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 8:23,142,733...23,149,067
Ensembl chr 8:23,142,734...23,148,396
|
|
G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
ISO IEP |
mRNA:decreased expression:subcutaneous adipose tissue CTD Direct Evidence: marker/mechanism mRNA, protein:increased expression:adipose tissue, liver |
CTD |
PMID:20882379, PMID:16788709, PMID:1543733 |
RGD:1625735, RGD:1625737 |
NCBI chr16:48,937,456...49,003,898
Ensembl chr16:48,937,456...49,003,246
|
|
G |
Ada |
adenosine deaminase |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:16501670 |
RGD:1624289 |
NCBI chr 3:160,115,840...160,139,947
Ensembl chr 3:160,115,842...160,139,947
|
|
G |
Adarb1 |
adenosine deaminase, RNA-specific, B1 |
|
IMP |
associated with Hyperphagia |
RGD |
PMID:17567573 |
RGD:10450894 |
NCBI chr20:11,972,352...12,101,022
Ensembl chr20:11,972,381...12,101,047
|
|
G |
Adcy3 |
adenylate cyclase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19 |
CTD ClinVar |
PMID:29311635 PMID:29311636 PMID:29311637 |
|
NCBI chr 6:28,570,941...28,648,848
Ensembl chr 6:28,571,351...28,650,148
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
treatment |
IEP ISO |
CTD Direct Evidence: marker/mechanism CTD Direct Evidence: marker/mechanism|therapeutic associated with Diabetes Mellitus, Type 2 associated with myocardial infarction; protein:decreased expression:plasma associated with Pulmonary Disease, Chronic Obstructive; protein:decreased expression:plasma |
CTD |
PMID:10092513 PMID:11549668 PMID:14617771, PMID:16092047, PMID:28843383, PMID:23731386, PMID:18651432, PMID:18303100, PMID:19606374 |
RGD:1599149, RGD:14975146, RGD:8695927, RGD:5686813, RGD:5686809, RGD:2313239 |
NCBI chr11:81,330,845...81,344,488
Ensembl chr11:81,330,293...81,344,488
|
|
G |
Adipor1 |
adiponectin receptor 1 |
|
IEP ISO |
mRNA:increased expression:liver mRNA:decreased expression:lymphocyte |
RGD |
PMID:16483885, PMID:17391161 |
RGD:1625763, RGD:1625761 |
NCBI chr13:51,240,470...51,260,233
Ensembl chr13:51,240,911...51,260,228
|
|
G |
Adipor2 |
adiponectin receptor 2 |
treatment severity |
IEP |
mRNA:increased expression:liver associated with non-alcoholic fatty liver disease mRNA:decreased expression:liver (rat) |
RGD |
PMID:16483885, PMID:30131158, PMID:23838384, PMID:30225267 |
RGD:1625763, RGD:25824942, RGD:8695926, RGD:21406435 |
NCBI chr 4:151,412,135...151,480,108
Ensembl chr 4:151,414,684...151,428,894
|
|
G |
Adm |
adrenomedullin |
|
ISO |
mRNA, protein:increased expression:adipose tissue |
RGD |
PMID:16793965 |
RGD:1625297 |
NCBI chr 1:175,443,189...175,447,260
Ensembl chr 1:175,445,088...175,447,259
|
|
G |
Adora1 |
adenosine A1 receptor |
|
ISO |
|
RGD |
PMID:16507638 |
RGD:1625369 |
NCBI chr13:51,042,111...51,076,913
Ensembl chr13:51,042,248...51,076,852
|
|
G |
Adra2a |
adrenoceptor alpha 2A |
|
ISO |
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr 1:274,766,283...274,769,083
Ensembl chr 1:274,766,283...274,769,081
|
|
G |
Adra2b |
adrenoceptor alpha 2B |
|
ISO |
|
RGD |
PMID:10404816 |
RGD:1300265 |
NCBI chr 3:119,805,941...119,809,987
Ensembl chr 3:119,805,941...119,809,987
|
|
G |
Adrb1 |
adrenoceptor beta 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12032746 |
|
NCBI chr 1:277,537,585...277,538,985
Ensembl chr 1:277,537,585...277,538,985
|
|
G |
Adrb2 |
adrenoceptor beta 2 |
susceptibility no_association |
ISO |
DNA:polymorphisms: :p.R16G, p.Q27E CTD Direct Evidence: marker/mechanism |
CTD OMIM |
PMID:15687340, PMID:17027833, PMID:12161655, PMID:15118671, PMID:17221209 |
RGD:1601122, RGD:737773, RGD:1331525, RGD:1601119 |
NCBI chr18:57,513,792...57,515,834
Ensembl chr18:57,513,793...57,515,834
|
|
G |
Adrb3 |
adrenoceptor beta 3 |
no_association |
ISO |
DNA:missense mutation:cds:p.W64R (human) ClinVar Annotator: match by OMIM:601665 DNA:polymorphisms, haplotype:cds, intron, 3' utr:g.827T>C rs4994, g.1856G>T, g.3139G>C (human) DNA:missense mutation:cds:p.W64R rs4994 (human) mRNA:decreased expression:interscapular region, brown adipose tissue (mouse) |
ClinVar OMIM |
PMID:7609750 PMID:7609752 PMID:8903328 PMID:8954053 PMID:9054940 PMID:9100608 PMID:9112025 PMID:9449691 PMID:9709965 PMID:9814483 PMID:9892244 PMID:10323390 PMID:10323402 PMID:10999801 PMID:11095426 PMID:15472194, PMID:9126344, PMID:9892244, PMID:11882399, PMID:19373220 |
RGD:1559325, RGD:5684773, RGD:5684409, RGD:5684359 |
NCBI chr16:69,003,541...69,006,632
Ensembl chr16:69,003,868...69,006,632
|
|
G |
Aff4 |
AF4/FMR2 family, member 4 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25730767 |
|
NCBI chr10:38,692,167...38,773,021
Ensembl chr10:38,692,211...38,773,021
|
|
G |
Agap2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
|
ISO |
|
RGD |
PMID:20068140 |
RGD:13838849 |
NCBI chr 7:70,360,199...70,377,422
Ensembl chr 7:70,364,813...70,377,422
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
|
ISO |
protein:decreased expression:plasma (human) |
RGD |
PMID:23046363, PMID:22761461 |
RGD:7243247, RGD:7243250 |
NCBI chr20:4,363,152...4,366,079
Ensembl chr20:4,363,152...4,366,079
|
|
G |
Agrp |
agouti related neuropeptide |
|
IEP ISO |
mRNA:increased expression:hypothalamus ClinVar Annotator: match by term: Obesity, late-onset DNA:polymorphism:promoter:-38C>T (human) DNA:polymorphism:exon:c.199G>A, pAla67Thr (human) |
ClinVar OMIM |
PMID:11602360 PMID:12213871 PMID:15054840, PMID:18001323, PMID:15118671, PMID:11554767, PMID:11344185, PMID:12213871 |
RGD:2311538, RGD:1331525, RGD:2314000, RGD:1300272, RGD:1625232 |
NCBI chr19:37,525,941...37,584,875
Ensembl chr19:37,526,419...37,528,011
|
|
G |
Agt |
angiotensinogen |
susceptibility |
ISO |
DNA:polymorphism: :p.M235T DNA:polymorphism: :p.T174M |
RGD |
PMID:16713443, PMID:16514903 |
RGD:1601142, RGD:1601143 |
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
|
|
G |
Agtr2 |
angiotensin II receptor, type 2 |
|
ISO |
|
RGD |
PMID:15793237 |
RGD:2313554 |
NCBI chr X:119,389,480...119,393,845
Ensembl chr X:119,390,013...119,393,842
|
|
G |
Ahi1 |
Abelson helper integration site 1 |
|
ISO |
mRNA:increased expression:vastus lateralis |
RGD |
PMID:20045148 |
RGD:11537398 |
NCBI chr 1:16,478,127...16,601,769
Ensembl chr 1:16,478,127...16,601,769
|
|
G |
Ahr |
aryl hydrocarbon receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27020609 PMID:30813227 PMID:31306034 |
|
NCBI chr 6:54,963,990...55,001,806
Ensembl chr 6:54,963,990...55,001,464
|
|
G |
Ahsg |
alpha-2-HS-glycoprotein |
susceptibility |
ISO |
protein:increased expression:serum |
RGD |
PMID:17011519, PMID:19228823, PMID:17011519 |
RGD:1625793, RGD:2313809, RGD:1625793 |
NCBI chr11:81,711,269...81,717,594
|
|
G |
Ak1 |
adenylate kinase 1 |
|
ISO |
protein:increased expression:skeletal muscle |
RGD |
PMID:15855311 |
RGD:1601154 |
NCBI chr 3:11,652,143...11,659,135
|
|
G |
Akap1 |
A-kinase anchoring protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20975297 |
|
NCBI chr10:76,151,013...76,183,987
Ensembl chr10:76,151,038...76,166,276
|
|
G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
|
ISO |
mRNA, protein:increased expression:adipose tissue |
RGD |
PMID:15494612 |
RGD:1626148 |
NCBI chr17:69,441,253...69,460,334
Ensembl chr17:69,441,223...69,460,321
|
|
G |
Akr1c2 |
aldo-keto reductase family 1, member C2 |
|
ISO |
mRNA, protein:increased expression:adipose tissue |
RGD |
PMID:15494612 |
RGD:1626148 |
NCBI chr17:69,388,337...69,435,160
Ensembl chr17:69,388,335...69,404,341
|
|
G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr17:69,761,126...69,778,021
Ensembl chr17:69,761,118...69,778,021
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23954404 |
|
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
|
|
G |
Akt2 |
AKT serine/threonine kinase 2 |
|
ISO IEP |
protein:decreased activity:rectus abdominis (human) protein:decreased expression:plantaris (rat) |
RGD |
PMID:12663464, PMID:18508911, PMID:17923673 |
RGD:2313409, RGD:2313320, RGD:2313406 |
NCBI chr 1:84,400,939...84,451,223
Ensembl chr 1:84,411,726...84,450,162
|
|
G |
Aldh1l1 |
aldehyde dehydrogenase 1 family, member L1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 4:123,516,553...123,564,067
Ensembl chr 4:123,516,788...123,557,501
|
|
G |
Aldh6a1 |
aldehyde dehydrogenase 6 family, member A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 6:108,146,552...108,167,185
Ensembl chr 6:108,146,582...108,167,185
|
|
G |
Alms1 |
ALMS1, centrosome and basal body associated protein |
|
ISS |
OMIM:601665 |
MouseDO |
|
|
NCBI chr 4:117,371,544...117,472,310
Ensembl chr 4:117,371,659...117,472,198
|
|
G |
Alox12 |
arachidonate 12-lipoxygenase, 12S type |
|
IEP ISO |
mRNA:increased expression:adipose tissue, fat cell |
RGD |
PMID:20978234, PMID:18780776 |
RGD:5509594, RGD:5509628 |
NCBI chr10:56,851,734...56,864,049
Ensembl chr10:56,851,734...56,864,005
|
|
G |
Alox5ap |
arachidonate 5-lipoxygenase activating protein |
|
ISO |
mRNA:increased expression:adipose tissue (mouse) mRNA:increased expression:peripheral blood mononuclear cell (human) |
RGD |
PMID:17379835, PMID:19596146 |
RGD:2313913, RGD:2313884 |
NCBI chr12:6,854,930...6,879,112
Ensembl chr12:6,854,920...6,879,154
|
|
G |
Amh |
anti-Mullerian hormone |
|
ISO |
protein:decreased expression:serum |
RGD |
PMID:17109858 |
RGD:1601182 |
NCBI chr 7:11,775,155...11,777,503
Ensembl chr 7:11,775,155...11,777,503
|
|
G |
Ang |
angiogenin |
|
ISO |
protein:increased expression:adipose tissue |
RGD |
PMID:22748184 |
RGD:6892722 |
NCBI chr15:28,022,926...28,028,636
|
|
G |
Angptl4 |
angiopoietin-like 4 |
resistance |
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:28842503, PMID:17210919 |
RGD:1625353 |
NCBI chr 7:18,627,814...18,634,043
Ensembl chr 7:18,627,808...18,634,079
|
|
G |
Angptl6 |
angiopoietin-like 6 |
|
ISS |
OMIM:601665 |
MouseDO |
|
|
NCBI chr 8:21,895,523...21,902,002
Ensembl chr 8:21,895,524...21,901,829
|
|
G |
Ankrd26 |
ankyrin repeat domain 26 |
|
ISO ISS |
OMIM:601665 |
MouseDO |
PMID:18162531 |
RGD:9681744 |
NCBI chr 4:150,548,656...150,616,928
Ensembl chr 4:150,547,467...150,616,895
|
|
G |
Aoc3 |
amine oxidase, copper containing 3 |
|
IMP |
|
RGD |
PMID:17977742 |
RGD:2313916 |
NCBI chr10:89,251,370...89,259,313
Ensembl chr10:89,251,370...89,259,313
|
|
G |
Apcdd1 |
APC down-regulated 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28242765 |
|
NCBI chr18:58,270,398...58,300,982
Ensembl chr18:58,270,410...58,301,002
|
|
G |
Apln |
apelin |
|
IEP |
mRNA:increased expression:subcutaneous adipose tissue |
RGD |
PMID:17594060 |
RGD:1626170 |
NCBI chr X:134,856,719...134,866,210
Ensembl chr X:134,856,726...134,866,210
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
protein:decreased expression |
RGD |
PMID:9933608, PMID:12725089 |
RGD:2313959, RGD:1601185 |
NCBI chr 8:50,525,091...50,526,875
Ensembl chr 8:50,525,091...50,526,875
|
|
G |
Apoa2 |
apolipoprotein A2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:9933608, PMID:9002300 |
RGD:2313959, RGD:1601191 |
NCBI chr13:89,596,872...89,598,805
Ensembl chr13:89,597,138...89,598,802
|
|
G |
Apoa4 |
apolipoprotein A4 |
|
ISO |
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr 8:50,536,983...50,539,371
Ensembl chr 8:50,537,009...50,539,376
|
|
G |
Apoa5 |
apolipoprotein A5 |
|
ISO |
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr 8:50,559,079...50,561,720
Ensembl chr 8:50,559,126...50,561,736
|
|
G |
Apob |
apolipoprotein B |
|
ISO |
associated with Insulin Resistance;protein:increased expression:plasma |
RGD GAD |
PMID:19592617, PMID:15118671 |
RGD:2313974, RGD:1331525 |
NCBI chr 6:33,176,826...33,216,381
Ensembl chr 6:33,176,778...33,224,997
|
|
G |
Apobec1 |
apolipoprotein B mRNA editing enzyme catalytic subunit 1 |
|
IEP |
mRNA:increased expression:liver |
RGD |
PMID:8781289 |
RGD:1626278 |
NCBI chr 4:155,386,367...155,414,034
Ensembl chr 4:155,386,711...155,401,480
|
|
G |
Apoc1 |
apolipoprotein C1 |
|
ISO |
|
RGD |
PMID:11723061 |
RGD:2313951 |
NCBI chr 1:80,606,638...80,609,921
Ensembl chr 1:80,606,638...80,609,921
|
|
G |
Apoc2 |
apolipoprotein C2 |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:9002300 |
RGD:1601191 |
NCBI chr 1:80,589,023...80,593,991
Ensembl chr 1:80,589,023...80,594,136
|
|
G |
Apoc3 |
apolipoprotein C3 |
|
ISO |
protein:increased expression:serum |
RGD GAD |
PMID:9002300, PMID:15118671 |
RGD:1601191, RGD:1331525 |
NCBI chr 8:50,529,318...50,531,498
Ensembl chr 8:50,529,318...50,531,498
|
|
G |
Apod |
apolipoprotein D |
|
ISO |
DNA:polymorphism |
RGD |
PMID:7913935 |
RGD:2311179 |
NCBI chr11:72,705,204...72,726,263
Ensembl chr11:72,705,129...72,726,301
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
protein:increased expression:serum CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20975297, PMID:9002300, PMID:17192461, PMID:15118671 |
RGD:1601191, RGD:1601230, RGD:1331525 |
NCBI chr 1:80,612,894...80,616,820
Ensembl chr 1:80,612,895...80,617,057
|
|
G |
App |
amyloid beta precursor protein |
treatment |
ISO |
mRNA,protein:increased expression:adipocyte,plasma: |
RGD |
PMID:19672057 |
RGD:10054260 |
NCBI chr11:24,425,013...24,641,872
Ensembl chr11:24,425,005...24,641,858
|
|
G |
Aqp7 |
aquaporin 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16325777 |
|
NCBI chr 5:57,358,297...57,372,332
Ensembl chr 5:57,358,327...57,372,239
|
|
G |
Ar |
androgen receptor |
susceptibility |
ISO ISS |
DNA:repeats: :GGN, CAG OMIM:601665 associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:repeat: :CAG |
MouseDO |
PMID:12532157, PMID:18805913, PMID:15118671 |
RGD:1601246, RGD:2306771, RGD:1331525 |
NCBI chr X:67,656,253...67,828,998
Ensembl chr X:67,656,253...67,829,026
|
|
G |
Arl13b |
ADP-ribosylation factor like GTPase 13B |
|
ISO |
protein:decreased expression:hypothalamus, cilium (mouse) |
RGD |
PMID:22581473 |
RGD:11553936 |
NCBI chr 7:1,122,567...1,188,209
Ensembl chr 7:1,122,567...1,188,209
|
|
G |
Asip |
agouti signaling protein |
susceptibility |
ISO |
DNA, mRNA:deletion, insertions, increased expression: multiple organs CTD Direct Evidence: marker/mechanism |
CTD |
PMID:1473152 PMID:8146154 PMID:25447408 PMID:25448685, PMID:7987393 |
RGD:1625724 |
NCBI chr 3:150,492,010...150,579,870
Ensembl chr 3:150,574,473...150,579,870
|
|
G |
Atp1a2 |
ATPase Na+/K+ transporting subunit alpha 2 |
susceptibility |
ISO |
|
RGD |
PMID:16286513 |
RGD:1601250 |
NCBI chr13:90,651,682...90,676,629
Ensembl chr13:90,651,686...90,676,629
|
|
G |
Atp4b |
ATPase H+/K+ transporting subunit beta |
treatment |
IDA |
|
RGD |
PMID:25822172 |
RGD:14696745 |
NCBI chr16:81,136,218...81,145,131
Ensembl chr16:81,136,218...81,145,131
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
treatment |
IDA |
|
RGD |
PMID:26880535 |
RGD:13782133 |
NCBI chr 7:2,504,708...2,511,748
Ensembl chr 7:2,504,695...2,511,749
|
|
G |
Atp5f1c |
ATP synthase F1 subunit gamma |
|
ISO |
|
RGD |
PMID:19549744 |
RGD:14696798 |
NCBI chr17:72,209,321...72,231,562
Ensembl chr17:72,209,373...72,394,271
|
|
G |
Atp5f1d |
ATP synthase F1 subunit delta |
treatment |
IDA |
|
RGD |
PMID:27874268 |
RGD:13792665 |
NCBI chr 7:12,426,807...12,432,120
Ensembl chr 7:12,426,809...12,432,130
|
|
G |
Atp5mc2 |
ATP synthase membrane subunit c locus 2 |
|
ISO |
|
RGD |
PMID:26709097 |
RGD:11535661 |
NCBI chr 7:144,264,207...144,272,578
Ensembl chr 7:144,264,199...144,272,578
|
|
G |
Atpaf1 |
ATP synthase mitochondrial F1 complex assembly factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 5:134,641,618...134,667,079
Ensembl chr 5:134,641,608...134,667,084
|
|
G |
Atrn |
attractin |
|
ISO |
|
RGD |
PMID:10086355 |
RGD:734623 |
NCBI chr 3:123,434,409...123,567,922
Ensembl chr 3:123,434,409...123,567,918
|
|
G |
B2m |
beta-2 microglobulin |
|
ISO |
protein:increased expression:urine |
RGD |
PMID:15517379 |
RGD:1601309 |
NCBI chr 3:114,087,287...114,093,311
Ensembl chr 3:114,087,287...114,093,309
|
|
G |
Bad |
BCL2-associated agonist of cell death |
|
IEP |
protein:increased expression:heart left ventricle |
RGD |
PMID:18070754 |
RGD:2292682 |
NCBI chr 1:222,198,516...222,207,459
Ensembl chr 1:222,198,534...222,207,453
|
|
G |
Bambi |
BMP and activin membrane-bound inhibitor |
|
ISO |
mRNA:decreased expression:adipose tissue |
RGD |
PMID:22187378 |
RGD:14390162 |
NCBI chr17:56,905,419...56,909,675
Ensembl chr17:56,905,112...56,909,992
|
|
G |
Bbs1 |
Bardet-Biedl syndrome 1 |
no_association |
ISO ISS |
DNA:mutation: :p.M390R (human) OMIM:601665 |
MouseDO |
PMID:14993910 |
RGD:1601314 |
NCBI chr 1:220,146,084...220,165,545
Ensembl chr 1:220,147,327...220,165,678
|
|
G |
Bbs2 |
Bardet-Biedl syndrome 2 |
susceptibility |
ISO |
DNA:SNPs |
RGD |
PMID:17003356 |
RGD:1601311 |
NCBI chr19:11,385,921...11,421,523
Ensembl chr19:11,386,024...11,421,498
|
|
G |
Bbs4 |
Bardet-Biedl syndrome 4 |
onset |
ISO ISS |
DNA:SNPs OMIM:601665 |
MouseDO |
PMID:17003356 |
RGD:1601311 |
NCBI chr 8:64,115,005...64,154,432
Ensembl chr 8:64,121,392...64,154,396
|
|
G |
Bche |
butyrylcholinesterase |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:18452903 PMID:23000450 PMID:23073171 PMID:27163854 |
|
NCBI chr 2:171,104,476...171,196,186
Ensembl chr 2:171,100,140...171,196,395
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
|
IEP |
mRNA, protein:decreased expression:heart left ventricle |
RGD |
PMID:18202171 |
RGD:2293027 |
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Bdkrb1 |
bradykinin receptor B1 |
|
ISO |
|
RGD |
PMID:17184856 |
RGD:1625733 |
NCBI chr 6:129,437,423...129,441,553
Ensembl chr 6:129,438,158...129,440,574
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
ISO |
protein:decreased expression:plasma ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:11840487 PMID:25741868, PMID:17151862 |
RGD:10059350 |
NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
|
IEP |
|
RGD |
PMID:18070754 |
RGD:2292682 |
NCBI chr 1:211,248,098...211,265,282
Ensembl chr 1:211,248,098...211,265,282
|
|
G |
Brd2 |
bromodomain containing 2 |
|
ISO |
|
RGD |
PMID:19883376 |
RGD:9586446 |
NCBI chr20:3,910,555...3,921,074
Ensembl chr20:3,910,555...3,917,426 Ensembl chr20:3,910,555...3,917,426
|
|
G |
Brs3 |
bombesin receptor subtype 3 |
|
ISO |
|
RGD |
PMID:9367152 |
RGD:734661 |
NCBI chr X:159,484,953...159,510,944
Ensembl chr X:159,505,344...159,511,021
|
|
G |
C3 |
complement C3 |
treatment |
IDA |
|
RGD |
PMID:23118029 |
RGD:7411625 |
NCBI chr 9:9,721,137...9,747,084
Ensembl chr 9:9,721,105...9,747,167
|
|
G |
C5ar1 |
complement C5a receptor 1 |
treatment |
IDA |
|
RGD |
PMID:23118029 |
RGD:7411625 |
NCBI chr 1:78,186,777...78,195,132
Ensembl chr 1:78,186,776...78,195,328
|
|
G |
Ca3 |
carbonic anhydrase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 2:88,126,519...88,136,063
Ensembl chr 2:88,126,667...88,135,410
|
|
G |
Cadm2 |
cell adhesion molecule 2 |
|
ISO |
DNA:SNP: :rs13078807 (human) |
RGD |
PMID:31341224 |
RGD:15092077 |
NCBI chr11:4,175,078...4,397,335
Ensembl chr11:4,174,881...4,397,361
|
|
G |
Canx |
calnexin |
|
ISO |
protein:increased expression:subcutaneous adipose tissue |
RGD |
PMID:18567819 |
RGD:2314284 |
NCBI chr10:35,800,942...35,833,939
Ensembl chr10:35,800,942...35,833,861
|
|
G |
Capn10 |
calpain 10 |
|
ISO |
DNA:SNPs |
RGD |
PMID:16752174 |
RGD:1625047 |
NCBI chr 9:100,104,000...100,112,833
Ensembl chr 9:100,104,000...100,112,832
|
|
G |
Cartpt |
CART prepropeptide |
no_association |
ISO |
DNA:deletion, substitution: :1457delA, 1475A>G (human) ClinVar Annotator: match by OMIM:601665 DNA:polymorphism:3' utr (human) DNA:missense mutation:exon:729G>C, p.L34F (human) |
OMIM ClinVar |
PMID:11522684 PMID:15326462, PMID:10574510, PMID:10805512, PMID:11522684 |
RGD:2313634, RGD:2313633, RGD:1625192 |
NCBI chr 2:30,125,249...30,127,408
Ensembl chr 2:30,125,249...30,127,269
|
|
G |
Casp1 |
caspase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22325453 |
|
NCBI chr 8:2,605,743...2,614,637
Ensembl chr 8:2,604,962...2,614,631
|
|
G |
Cav1 |
caveolin 1 |
|
IEP |
|
RGD |
PMID:22492718 |
RGD:6784520 |
NCBI chr 4:44,597,123...44,630,206
Ensembl chr 4:44,597,123...44,630,200
|
|
G |
Cav2 |
caveolin 2 |
|
IEP |
|
RGD |
PMID:22492718 |
RGD:6784520 |
NCBI chr 4:44,573,264...44,580,640
Ensembl chr 4:44,573,264...44,580,638
|
|
G |
Cckar |
cholecystokinin A receptor |
|
IAGP ISO |
DNA:deletion |
RGD |
PMID:9530226, PMID:9192855 |
RGD:7257724, RGD:734711 |
NCBI chr14:59,610,939...59,619,786
Ensembl chr14:59,611,434...59,619,783
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
|
ISO IEP |
protein, mRNA:increased expression:plasma, fat CTD Direct Evidence: marker/mechanism protein:increased expression:serum |
CTD |
PMID:29035695, PMID:17803693, PMID:18469848 |
RGD:2306993, RGD:2307038 |
NCBI chr10:69,412,065...69,413,863
Ensembl chr10:69,412,017...69,413,870
|
|
G |
Ccl4 |
C-C motif chemokine ligand 4 |
|
IEP |
|
RGD |
PMID:21862610 |
RGD:5683906 |
NCBI chr10:70,870,926...70,886,357
Ensembl chr10:70,884,531...70,886,355
|
|
G |
Ccl5 |
C-C motif chemokine ligand 5 |
|
IEP |
protein:increased expression:serum |
RGD |
PMID:18469848 |
RGD:2307038 |
NCBI chr10:70,739,764...70,744,303
Ensembl chr10:70,739,800...70,744,315
|
|
G |
Ccl7 |
C-C motif chemokine ligand 7 |
|
ISO |
|
RGD |
PMID:18492752 |
RGD:6483834 |
NCBI chr10:69,423,083...69,424,933
Ensembl chr10:69,423,086...69,424,979
|
|
G |
Ccr3 |
C-C motif chemokine receptor 3 |
|
ISO |
mRNA:increased expression:adipose tissue |
RGD |
PMID:18492752 |
RGD:6483834 |
NCBI chr 8:133,026,539...133,040,999
Ensembl chr 8:133,029,625...133,040,997
|
|
G |
Cd163 |
CD163 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29035695 |
|
NCBI chr 4:156,752,063...156,785,467
Ensembl chr 4:156,752,082...156,785,467
|
|
G |
Cd36 |
CD36 molecule |
|
IEP IMP ISO |
mRNA, protein:increased expression:liver, gastrocnemius protein:increased expression:skeletal muscle, T-tubule |
RGD |
PMID:20435456, PMID:25477422, PMID:23743348, PMID:22615812 |
RGD:6893497, RGD:11041132, RGD:11041118, RGD:6893542 |
NCBI chr 4:14,150,309...14,191,498
Ensembl chr 4:14,001,761...14,249,749
|
|
G |
Cd40 |
CD40 molecule |
treatment |
IDA ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29035695, PMID:21670556 |
RGD:7248753 |
NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
|
|
G |
Cd40lg |
CD40 ligand |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:21817098, PMID:20660932 |
RGD:5490592, RGD:5490970 |
NCBI chr X:159,703,703...159,714,886
Ensembl chr X:159,703,578...159,716,562
|
|
G |
Cd68 |
Cd68 molecule |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29035695 |
|
NCBI chr10:56,268,726...56,270,605
Ensembl chr10:56,268,720...56,270,640
|
|
G |
Cdk4 |
cyclin-dependent kinase 4 |
susceptibility |
ISO |
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:polymorphism:intron:IVS4-40G>A (human) |
RGD |
PMID:19634152 |
RGD:2314609 |
NCBI chr 7:70,345,971...70,352,689
Ensembl chr 7:70,349,863...70,352,418
|
|
G |
Cdkal1 |
CDK5 regulatory subunit associated protein 1-like 1 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
|
|
NCBI chr17:36,451,031...37,157,882
Ensembl chr17:36,451,058...37,295,069
|
|
G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
IEP |
protein:decreased expression:liver |
RGD |
PMID:23357529 |
RGD:10045356 |
NCBI chr 4:168,689,043...168,694,159
Ensembl chr 4:168,689,163...168,693,964
|
|
G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
IEP |
|
RGD |
PMID:22194422 |
RGD:8552660 |
NCBI chr 5:107,823,323...107,832,405
Ensembl chr 5:107,823,330...107,841,175
|
|
G |
Cdo1 |
cysteine dioxygenase type 1 |
|
ISO |
|
RGD |
PMID:16627576 |
RGD:2301355 |
NCBI chr18:40,702,027...40,716,901
Ensembl chr18:40,701,984...40,716,686
|
|
G |
Cebpa |
CCAAT/enhancer binding protein alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28242765 |
|
NCBI chr 1:91,363,492...91,366,164
Ensembl chr 1:91,363,492...91,366,164
|
|
G |
Cenpo |
centromere protein O |
|
ISO |
ClinVar Annotator: match by term: BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19 |
ClinVar |
PMID:29311637 |
|
NCBI chr 6:28,648,804...28,663,527
Ensembl chr 6:28,649,638...28,663,233
|
|
G |
Ces1d |
carboxylesterase 1D |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20975297 |
|
NCBI chr19:15,195,514...15,239,827
Ensembl chr19:15,033,108...15,239,821
|
|
G |
Cfd |
complement factor D |
|
IEP ISO |
mRNA, protein:decreased expression:adipocyte, serum |
RGD |
PMID:2197880, PMID:14564690 |
RGD:1624327, RGD:1624324 |
NCBI chr 7:12,634,216...12,635,939
Ensembl chr 7:12,634,216...12,635,943
|
|
G |
Cidea |
cell death-inducing DFFA-like effector a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20975297, PMID:16186410 |
RGD:1625390 |
NCBI chr18:63,082,861...63,108,450
Ensembl chr18:63,098,144...63,108,051
|
|
G |
Cnr1 |
cannabinoid receptor 1 |
no_association |
ISO IMP |
DNA:polymorphism:exon:3813A>G (human) CTD Direct Evidence: marker/mechanism DNA:polymorphism: :1256C>A, 1419+1G>C (human) |
CTD |
PMID:18722357, PMID:17405839, PMID:19325539, PMID:19530697, PMID:17292652 |
RGD:1626325, RGD:2314630, RGD:2314629, RGD:1626326 |
NCBI chr 5:49,307,584...49,333,064
Ensembl chr 5:49,311,030...49,333,056
|
|
G |
Cntf |
ciliary neurotrophic factor |
no_association |
ISO |
DNA:point mutation:intron:G>A |
RGD |
PMID:14747836, PMID:12404108 |
RGD:1626114, RGD:1626113 |
NCBI chr 1:229,599,009...229,601,032
Ensembl chr 1:229,599,009...229,601,032
|
|
G |
Comt |
catechol-O-methyltransferase |
susceptibility |
ISO |
DNA:polymorphism:exon |
RGD |
PMID:17497175 |
RGD:2289713 |
NCBI chr11:86,715,981...86,735,630
Ensembl chr11:86,715,981...86,735,622
|
|
G |
Cox7c |
cytochrome c oxidase subunit 7C |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 2:14,699,878...14,701,903
Ensembl chr 2:14,699,882...14,701,903
|
|
G |
Cox8b |
cytochrome c oxidase, subunit VIIIb |
|
IDA |
|
RGD |
PMID:16027000 |
RGD:2301397 |
NCBI chr 1:213,648,787...213,650,247
Ensembl chr 1:213,648,787...213,650,247
|
|
G |
Cpb2 |
carboxypeptidase B2 |
|
ISO |
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression, increased activity:plasma CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16959692, PMID:11836301 |
RGD:2313645 |
NCBI chr15:57,290,849...57,339,762
Ensembl chr15:57,290,849...57,339,760
|
|
G |
Cpe |
carboxypeptidase E |
no_association |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15358678 PMID:23434795, PMID:9662053, PMID:7663508 |
RGD:1626184, RGD:1626181 |
NCBI chr16:26,906,716...27,014,811
Ensembl chr16:26,906,716...27,014,813
|
|
G |
Cps1 |
carbamoyl-phosphate synthase 1 |
|
IEP |
|
RGD |
PMID:15481768 |
RGD:2303517 |
NCBI chr 9:74,113,437...74,236,274
Ensembl chr 9:74,124,016...74,236,274
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
|
IEP |
mRNA:decreased expression:liver |
RGD |
PMID:16751799 |
RGD:2311345 |
NCBI chr 1:218,568,157...218,629,679
Ensembl chr 1:218,569,510...218,629,678
|
|
G |
Crh |
corticotropin releasing hormone |
|
IDA |
|
RGD |
PMID:11564446 |
RGD:5508830 |
NCBI chr 2:104,459,999...104,461,863
Ensembl chr 2:104,459,999...104,461,863
|
|
G |
Crhbp |
corticotropin releasing hormone binding protein |
|
IEP |
mRNA:decreased expression:anterior pituitary gland (rat) |
RGD |
PMID:10600923 |
RGD:5508840 |
NCBI chr 2:25,141,471...25,153,334
Ensembl chr 2:25,141,471...25,153,334
|
|
G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
|
ISO |
DNA:SNP:CDS:861C>T (human) |
RGD |
PMID:14724656 |
RGD:1626226 |
NCBI chr10:92,191,473...92,233,662
Ensembl chr10:92,191,718...92,232,645
|
|
G |
Crp |
C-reactive protein |
disease_progression |
ISO IEP |
protein:increased expression:serum mRNA:increased expression:liver (rat) CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24042701, PMID:20660932, PMID:25612518 |
RGD:5490970, RGD:15045599 |
NCBI chr13:91,080,448...91,081,358
Ensembl chr13:91,054,974...91,093,713
|
|
G |
Cs |
citrate synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 7:2,752,680...2,778,963
Ensembl chr 7:2,752,680...2,778,963
|
|
G |
Cst3 |
cystatin C |
|
IEP ISO |
protein:increased expression:plasma (rat) protein:increased expression:serum (human) |
RGD |
PMID:18946178, PMID:18374694 |
RGD:2314297, RGD:2314346 |
NCBI chr 3:143,219,671...143,223,544
Ensembl chr 3:143,219,686...143,223,615
|
|
G |
Ctf1 |
cardiotrophin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21803294 |
|
NCBI chr 1:199,162,319...199,168,296
Ensembl chr 1:199,163,086...199,168,296
|
|
G |
Ctsc |
cathepsin C |
|
IEP |
|
RGD |
PMID:3705543 |
RGD:1599645 |
NCBI chr 1:151,918,514...151,949,979
Ensembl chr 1:151,918,571...151,949,983
|
|
G |
Ctss |
cathepsin S |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21156398 |
|
NCBI chr 2:197,655,780...197,679,768
Ensembl chr 2:197,655,786...197,679,458
|
|
G |
Cx3cr1 |
C-X3-C motif chemokine receptor 1 |
|
ISO |
DNA:SNP: :p.T280M (human) |
RGD |
PMID:20523302 |
RGD:4891903 |
NCBI chr 8:128,740,756...128,754,514
Ensembl chr 8:128,740,756...128,754,514
|
|
G |
Cxcr4 |
C-X-C motif chemokine receptor 4 |
|
ISO |
|
RGD |
PMID:25016030 |
RGD:13673852 |
NCBI chr13:45,314,952...45,318,856
Ensembl chr13:45,314,933...45,318,878
|
|
G |
Cyb5a |
cytochrome b5 type A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr18:81,694,818...81,726,821
Ensembl chr18:81,694,808...81,726,821
|
|
G |
Cycs |
cytochrome c, somatic |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16317704 |
|
NCBI chr 4:80,331,226...80,333,326
Ensembl chr 4:80,331,227...80,333,326
|
|
G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:27036855 |
|
NCBI chr 6:2,308,179...2,316,739
Ensembl chr 6:2,307,808...2,316,722
|
|
G |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 4:116,261,796...116,278,615
Ensembl chr 4:116,261,796...116,278,615
|
|
G |
Cyp27b1 |
cytochrome P450, family 27, subfamily b, polypeptide 1 |
susceptibility |
ISO |
associated with Diabetes Mellitus, Non-Insulin-Dependent;DNA:polymorphisms:promoter, intron:g.-1260C>A, g.2838T>C (human) |
RGD |
PMID:17223345 |
RGD:2307312 |
NCBI chr 7:70,333,150...70,340,006
Ensembl chr 7:70,335,061...70,340,005
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
IEP |
protein:decreased expression:liver |
RGD |
PMID:18589557 |
RGD:2301455 |
NCBI chr 7:99,142,431...99,183,540
Ensembl chr 7:99,142,450...99,181,783
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
IEP ISO |
protein:increased activity:liver,fat CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23954404, PMID:17049493 |
RGD:1626307 |
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Dcn |
decorin |
|
IEP |
|
RGD |
PMID:17244723 |
RGD:1600551 |
NCBI chr 7:38,742,250...38,782,282
Ensembl chr 7:38,742,051...38,782,323
|
|
G |
Dcxr |
dicarbonyl and L-xylulose reductase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr10:109,906,119...109,909,696
Ensembl chr10:109,906,815...109,909,715
|
|
G |
Ddhd2 |
DDHD domain containing 2 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:23176823 PMID:24337409 PMID:24517879 PMID:25417924 PMID:25741868 PMID:28492532 PMID:32488064 |
|
NCBI chr16:71,090,096...71,120,713
Ensembl chr16:71,090,045...71,118,552
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26655953 |
|
NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
|
|
G |
Deaf1 |
DEAF1 transcription factor |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:25741868 |
|
NCBI chr 1:214,283,787...214,317,466
Ensembl chr 1:214,283,790...214,317,466
|
|
G |
Defb1 |
defensin beta 1 |
|
IEP |
mRNA:decreased expression:kidney |
RGD |
PMID:11340353 |
RGD:4892260 |
NCBI chr16:75,294,385...75,309,127
Ensembl chr16:75,294,376...75,309,176
|
|
G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
no_association treatment |
ISO |
|
RGD |
PMID:14569040, PMID:18183944, PMID:10802663 |
RGD:1625597, RGD:10401058, RGD:734536 |
NCBI chr 7:117,566,363...117,576,735
Ensembl chr 7:117,566,368...117,576,737
|
|
G |
Dio2 |
iodothyronine deiodinase 2 |
no_association |
ISO |
|
RGD |
PMID:17077128 |
RGD:1626439 |
NCBI chr 6:114,475,156...114,489,443
Ensembl chr 6:114,476,142...114,476,723
|
|
G |
Dip2c |
disco-interacting protein 2 homolog C |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:25741868 |
|
NCBI chr17:63,426,688...63,810,183
Ensembl chr17:63,635,086...63,808,464
|
|
G |
Dixdc1 |
DIX domain containing 1 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
|
|
NCBI chr 8:55,091,232...55,164,636
Ensembl chr 8:55,091,235...55,162,421
|
|
G |
Dnm1l |
dynamin 1-like |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
|
|
NCBI chr11:88,830,968...88,882,271
Ensembl chr11:88,830,957...88,880,198
|
|
G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 2:221,823,692...222,694,627
Ensembl chr 2:221,823,687...222,694,627
|
|
G |
Drd1 |
dopamine receptor D1 |
treatment |
IEP IDA |
protein:increased serine phosphorylation:renal proximal tubule, membrane (rat) |
RGD |
PMID:15983225, PMID:17191082 |
RGD:7248449, RGD:7248552 |
NCBI chr17:11,099,736...11,104,352
Ensembl chr17:11,101,306...11,103,541
|
|
G |
Drd2 |
dopamine receptor D2 |
|
IEP ISO |
mRNA:decreased expression:ventral tegmental area (rat) DNA:polymorphism DNA:polymorphisms, haplotype:enhancer, promoter, intron:multiple |
RGD |
PMID:18477764, PMID:15939106, PMID:17108814 |
RGD:2311581, RGD:1600905, RGD:1600904 |
NCBI chr 8:53,678,777...53,743,643
Ensembl chr 8:53,678,777...53,743,642
|
|
G |
Drd4 |
dopamine receptor D4 |
|
ISO IEP |
protein:decreased expression:kidney (rat) |
GAD RGD |
PMID:15118671, PMID:20810614 |
RGD:1331525, RGD:7248616 |
NCBI chr 1:214,278,296...214,282,818
Ensembl chr 1:214,278,296...214,281,483
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
susceptibility |
ISO |
|
RGD |
PMID:16814733 |
RGD:2298673 |
NCBI chr10:16,970,642...16,973,425
Ensembl chr10:16,970,626...16,973,418
|
|
G |
Ech1 |
enoyl-CoA hydratase 1 |
treatment |
ISO |
|
RGD |
PMID:31961704 |
RGD:21408561 |
NCBI chr 1:87,009,798...87,015,996
Ensembl chr 1:87,009,730...87,016,005
|
|
G |
Echs1 |
enoyl-CoA hydratase, short chain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 1:212,570,213...212,579,040
Ensembl chr 1:212,570,195...212,579,057
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
DNA:polymorphism:exon:p.K198N (human) |
RGD |
PMID:17444275 |
RGD:1625065 |
NCBI chr17:22,136,814...22,143,745
Ensembl chr17:22,137,324...22,143,324
|
|
G |
Efnb1 |
ephrin B1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24098442 |
|
NCBI chr X:68,891,227...68,904,034
Ensembl chr X:68,891,227...68,904,038
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
protein:decreased phosphorylation:liver (mouse) |
RGD |
PMID:3624263 |
RGD:5131534 |
NCBI chr14:99,919,485...100,104,136
Ensembl chr14:99,919,485...100,098,796
|
|
G |
Ehd1 |
EH-domain containing 1 |
|
IEP |
|
RGD |
PMID:21365757 |
RGD:8661255 |
NCBI chr 1:221,644,867...221,667,242
Ensembl chr 1:221,644,867...221,667,239
|
|
G |
Elovl6 |
ELOVL fatty acid elongase 6 |
|
ISO |
mRNA,protein:increased expression:liver: |
RGD |
PMID:31988048 |
RGD:21403676 |
NCBI chr 2:234,187,490...234,296,124
Ensembl chr 2:234,189,105...234,296,145 Ensembl chr 2:234,189,105...234,296,145
|
|
G |
Emc1 |
ER membrane protein complex subunit 1 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
|
|
NCBI chr 5:157,820,908...157,846,226
Ensembl chr 5:157,820,908...157,846,226
|
|
G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
ISO |
Obesity, OMIM:601665;DNA:polymorphism ClinVar Annotator: match by term: Obesity ClinVar Annotator: match by OMIM:601665 |
ClinVar OMIM |
PMID:9662402 PMID:10453738 PMID:10480624 PMID:11739459 PMID:11771660 PMID:14671192 PMID:14988267 PMID:15001634 PMID:15126519 PMID:15677494 PMID:16025115 PMID:16607460 PMID:16609882 PMID:16968801 PMID:24033266, PMID:16025115 |
RGD:1601042 |
NCBI chr 1:21,748,201...21,813,205
Ensembl chr 1:21,748,261...21,813,371
|
|
G |
Entpd6 |
ectonucleoside triphosphate diphosphohydrolase 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29273807 |
|
NCBI chr 3:146,546,424...146,568,828
Ensembl chr 3:146,546,387...146,568,825
|
|
G |
Ep300 |
E1A binding protein p300 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26441656 |
|
NCBI chr 7:122,818,194...122,889,055
Ensembl chr 7:122,818,975...122,861,296
|
|
G |
Esr1 |
estrogen receptor 1 |
|
ISO IDA |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20667977, PMID:11095962, PMID:22230815 |
RGD:8553065, RGD:8553199 |
NCBI chr 1:41,192,029...41,594,799
Ensembl chr 1:41,192,824...41,594,796
|
|
G |
Esr2 |
estrogen receptor 2 |
|
IDA |
|
RGD |
PMID:22230815 |
RGD:8553199 |
NCBI chr 6:99,163,953...99,214,711
Ensembl chr 6:99,164,357...99,214,251
|
|
G |
Esrra |
estrogen related receptor, alpha |
no_association |
ISO |
|
RGD |
PMID:16755280 |
RGD:1625637 |
NCBI chr 1:222,168,729...222,178,842
Ensembl chr 1:222,168,730...222,178,725
|
|
G |
Etfdh |
electron transfer flavoprotein dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 2:178,367,547...178,389,641
Ensembl chr 2:178,367,549...178,389,608
|
|
G |
F2 |
coagulation factor II |
|
ISO IDA |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22841818, PMID:21210148, PMID:23628972 |
RGD:5147773, RGD:7387310 |
NCBI chr 3:80,529,468...80,542,993
Ensembl chr 3:80,529,428...80,543,031
|
|
G |
F7 |
coagulation factor VII |
|
ISO |
protein:increased activity:plasma (human) associated with Diabetes Mellitus, Non-Insulin-Dependent associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:increased activity:plasma (human) |
RGD |
PMID:19329212, PMID:9258277, PMID:14513073, PMID:16739871 |
RGD:2312379, RGD:2312404, RGD:2312395, RGD:1625710 |
NCBI chr16:81,824,610...81,834,923
Ensembl chr16:81,824,111...81,834,945
|
|
G |
Faah |
fatty acid amide hydrolase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19103437 PMID:20716455, PMID:15809662 |
RGD:1625726 |
NCBI chr 5:134,852,899...134,872,095
Ensembl chr 5:134,852,875...134,871,775
|
|
G |
Fabp1 |
fatty acid binding protein 1 |
|
ISO |
Western diet-induced obesity |
RGD |
PMID:17058218 |
RGD:1626440 |
NCBI chr 4:99,063,181...99,066,957
Ensembl chr 4:99,063,181...99,066,954
|
|
G |
Fabp2 |
fatty acid binding protein 2 |
onset no_association |
ISO |
DNA:polymorphism:CDS:p.A54T (human) |
RGD |
PMID:15620432, PMID:17211557, PMID:14981227 |
RGD:1578458, RGD:1626407, RGD:1626400 |
NCBI chr 2:227,080,912...227,083,654
Ensembl chr 2:227,080,924...227,083,501
|
|
G |
Fabp3 |
fatty acid binding protein 3 |
|
ISO |
associated with Diabetes Mellitus, Non-Insulin-Dependent;mRNA:decreased expression:skeletal muscle |
RGD |
PMID:17515913 |
RGD:2307328 |
NCBI chr 5:148,528,854...148,535,597
Ensembl chr 5:148,528,725...148,535,565
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
|
ISO |
|
RGD |
PMID:8910278 |
RGD:737747 |
NCBI chr 2:93,792,666...93,797,267
Ensembl chr 2:93,792,601...93,797,305
|
|
G |
Fadd |
Fas associated via death domain |
|
IEP |
protein:increased expression:heart left ventricle |
RGD |
PMID:18202171 |
RGD:2293027 |
NCBI chr 1:217,746,176...217,748,581
Ensembl chr 1:217,742,929...217,748,628
|
|
G |
Fads1 |
fatty acid desaturase 1 |
|
IEP |
protein:decreased expression:microsomes, liver |
RGD |
PMID:8446010 |
RGD:1625421 |
NCBI chr 1:226,234,034...226,249,118
Ensembl chr 1:226,234,074...226,249,138
|
|
G |
Fanca |
FA complementation group A |
|
ISO |
|
RGD |
PMID:22482891 |
RGD:11046266 |
NCBI chr19:56,067,548...56,126,075
Ensembl chr19:56,067,548...56,126,063
|
|
G |
Fancc |
FA complementation group C |
|
ISO |
|
RGD |
PMID:22482891 |
RGD:11046266 |
NCBI chr17:826,512...955,703
Ensembl chr17:833,509...955,615
|
|
G |
Fasn |
fatty acid synthase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr10:109,987,735...110,005,901
Ensembl chr10:109,987,735...110,005,901
|
|
G |
Fbxo11 |
F-box protein 11 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
|
|
NCBI chr 6:11,662,356...11,737,427
Ensembl chr 6:11,662,356...11,686,682
|
|
G |
Ffar4 |
free fatty acid receptor 4 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Body mass index quantitative trait locus 10 CTD Direct Evidence: marker/mechanism |
ClinVar CTD OMIM |
PMID:22343897 PMID:27068006 |
|
NCBI chr 1:256,786,124...256,804,156
Ensembl chr 1:256,786,124...256,804,156
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24184811 PMID:26797127 |
|
NCBI chr 1:101,595,579...101,596,822
Ensembl chr 1:101,595,579...101,596,822
|
|
G |
Fgfr1 |
Fibroblast growth factor receptor 1 |
|
IEP ISO |
mRNA:increased expression:hypothalamus: mRNA:increased expression:adipose tissue: |
RGD |
PMID:21430024, PMID:21430024 |
RGD:10402094, RGD:10402094 |
NCBI chr16:71,265,390...71,319,046
Ensembl chr16:71,266,248...71,319,449
|
|
G |
Fgg |
fibrinogen gamma chain |
|
IEP |
protein:decreased expression:plasma |
RGD |
PMID:22134356 |
RGD:11352709 |
NCBI chr 2:181,987,080...181,994,523
Ensembl chr 2:181,987,217...181,994,514
|
|
G |
Fggy |
FGGY carbohydrate kinase domain containing |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29220483 |
|
NCBI chr 5:114,516,860...114,901,571
Ensembl chr 5:114,516,889...114,901,564
|
|
G |
Foxa2 |
forkhead box A2 |
|
ISO |
|
RGD |
PMID:12865419 |
RGD:1627574 |
NCBI chr 3:142,383,084...142,387,493
Ensembl chr 3:142,383,278...142,387,481
|
|
G |
Foxc2 |
forkhead box C2 |
|
ISO |
DNA:polymorphism:5'ut:-512C>T(human) |
RGD |
PMID:15601967 |
RGD:1601218 |
NCBI chr19:53,044,379...53,047,081
Ensembl chr19:53,044,379...53,047,081
|
|
G |
Foxo3 |
forkhead box O3 |
|
IEP ISO |
protein:increased expression:myocardium: CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23954404, PMID:16467659 |
RGD:10402201 |
NCBI chr20:46,428,078...46,519,156
Ensembl chr20:46,428,124...46,519,144
|
|
G |
Ftl1 |
ferritin light chain 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 1:101,448,190...101,450,034
Ensembl chr 1:101,448,346...101,449,829
|
|
G |
Fto |
FTO, alpha-ketoglutarate dependent dioxygenase |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD OMIM |
PMID:17496892 PMID:19079260 PMID:19079261 PMID:19151714 PMID:19918250 PMID:21076408 |
|
NCBI chr19:16,774,549...17,115,098
Ensembl chr19:16,772,744...17,115,113
|
|
G |
Fxn |
frataxin |
|
ISO |
DNA:deletion:exon (mouse) |
RGD |
PMID:17404227 |
RGD:2307045 |
NCBI chr 1:242,123,975...242,152,834
Ensembl chr 1:242,123,975...242,152,834
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
|
ISO IEP |
mRNA, protein:increased expression:white fat associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:increased expression:liver |
RGD |
PMID:15923630, PMID:19230846 |
RGD:2307347, RGD:2307340 |
NCBI chr X:156,274,800...156,293,935
Ensembl chr X:156,274,800...156,293,926
|
|
G |
Gabra6 |
gamma-aminobutyric acid type A receptor subunit alpha6 |
|
IAGP |
DNA:polymorphism:3' utr:1519T>C, abdominal obesity and hypercortisolism |
RGD |
PMID:12080446 |
RGD:1626491 |
NCBI chr10:27,847,447...27,862,896
Ensembl chr10:27,847,439...27,862,868
|
|
G |
Gal |
galanin and GMAP prepropeptide |
no_association |
ISO |
protein:increased expression:plasma |
RGD |
PMID:15930442, PMID:11220530 |
RGD:1625748, RGD:1624334 |
NCBI chr 1:218,653,059...218,657,922
Ensembl chr 1:218,652,917...218,657,925
|
|
G |
Galp |
galanin-like peptide |
|
IEP |
mRNA:decreased expression:arcuate nucleus |
RGD |
PMID:15256810 |
RGD:2313739 |
NCBI chr 1:71,352,417...71,374,457
Ensembl chr 1:71,352,419...71,373,605
|
|
G |
Galr1 |
galanin receptor 1 |
no_association |
ISO |
|
RGD |
PMID:15930442 |
RGD:1625748 |
NCBI chr18:79,243,009...79,258,570
Ensembl chr18:79,243,009...79,258,570
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
treatment |
IEP |
|
RGD |
PMID:27987997 |
RGD:13792668 |
NCBI chr 4:157,676,336...157,680,322
Ensembl chr 4:157,676,595...157,679,962
|
|
G |
Gas7 |
growth arrest specific 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19270708 |
|
NCBI chr10:54,010,723...54,240,805
Ensembl chr10:54,126,486...54,236,476
|
|
G |
Gcg |
glucagon |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20065960 |
|
NCBI chr 3:48,442,635...48,451,650
Ensembl chr 3:48,442,635...48,451,650
|
|
G |
Gck |
glucokinase |
|
IDA |
DNA, mRNA, protein:hypermethylation, increased expression:liver |
RGD |
PMID:21239437 |
RGD:7488967 |
NCBI chr14:86,149,146...86,191,589
Ensembl chr14:86,148,928...86,190,659
|
|
G |
Gckr |
glucokinase regulator |
no_association |
ISO |
|
RGD |
PMID:12739015 |
RGD:1626607 |
NCBI chr 6:26,355,296...26,385,761
Ensembl chr 6:26,355,296...26,385,761
|
|
G |
Gfpt1 |
glutamine fructose-6-phosphate transaminase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379, PMID:11118009 |
RGD:1625423 |
NCBI chr 4:118,852,046...118,901,583
Ensembl chr 4:118,852,062...118,901,591
|
|
G |
Gh1 |
growth hormone 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:8923850 |
|
NCBI chr10:94,486,204...94,488,181
Ensembl chr10:94,486,205...94,488,180
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
|
ISO |
ClinVar Annotator: match by term: Obesity, age at onset of ClinVar Annotator: match by OMIM:601665 |
OMIM ClinVar |
PMID:11502844 PMID:12050239 PMID:12161552 PMID:16204371 |
|
NCBI chr 4:145,674,157...145,678,066
Ensembl chr 4:145,674,157...145,678,066
|
|
G |
Ghsr |
growth hormone secretagogue receptor |
|
ISO |
DNA:point mutation:exon:F279L |
RGD |
PMID:16511600 |
RGD:1625270 |
NCBI chr 2:113,065,953...113,071,265
Ensembl chr 2:113,066,885...113,070,261
|
|
G |
Gip |
gastric inhibitory polypeptide |
|
ISO IEP |
associated with Polycystic Ovary Syndrome; protein:increased expression:plasma (human) protein:increased expression:plasma (rat) |
RGD |
PMID:3546047, PMID:19375579, PMID:18063845 |
RGD:2312551, RGD:2312588, RGD:2312547 |
NCBI chr10:83,835,080...83,848,399
Ensembl chr10:83,840,303...83,848,396
|
|
G |
Gipr |
gastric inhibitory polypeptide receptor |
susceptibility |
ISO |
mRNA:reduced expression:fat tissue (human) mRNA:splice variant:pancreatic islet (mouse) DNA:polymorphism:intron 1 C>A (rs2302382) (human) |
RGD |
PMID:12068290, PMID:17395281, PMID:17971513, PMID:19254363 |
RGD:737714, RGD:2312616, RGD:2312612, RGD:2312615 |
NCBI chr 1:80,063,047...80,073,223
Ensembl chr 1:80,063,049...80,073,223
|
|
G |
Gja5 |
gap junction protein, alpha 5 |
|
IEP |
mRNA, protein:decreased expression:mesenteric artery |
RGD |
PMID:18324386 |
RGD:7207466 |
NCBI chr 2:199,162,745...199,184,942
Ensembl chr 2:199,162,745...199,184,939
|
|
G |
Gldc |
glycine decarboxylase |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:10873393 PMID:11286506 PMID:12126939 PMID:15670722 PMID:15791207 PMID:17361008 PMID:25741868 PMID:26179960 PMID:27362913 PMID:28492532 |
|
NCBI chr 1:248,295,140...248,377,122
Ensembl chr 1:248,297,331...248,377,093
|
|
G |
Glp1r |
glucagon-like peptide 1 receptor |
|
IEP |
mRNA:decreased expression:hypothalamus medial zone |
RGD |
PMID:15279492 |
RGD:1624351 |
NCBI chr20:9,586,075...9,626,228
Ensembl chr20:9,586,075...9,626,228
|
|
G |
Glrx |
glutaredoxin |
|
IEP |
protein:increased expression:renal visceral adipose: |
RGD |
PMID:23404913 |
RGD:9686064 |
NCBI chr 2:2,606,032...2,615,944
Ensembl chr 2:2,605,996...2,615,944
|
|
G |
Glul |
glutamate-ammonia ligase |
|
IDA ISO |
protein:increased activity:skeletal muscle:activity is increased in Zucker fa/fa genetically obese but not dietary obese (fa/?) rats vs non-obese (fa/?) rats CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379, PMID:15481771 |
RGD:2301479 |
NCBI chr13:71,331,052...71,340,207
Ensembl chr13:71,331,052...71,340,229
|
|
G |
Gnas |
GNAS complex locus |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Obesity associated with Polycystic Ovary Syndrome;DNA:polymorphism: :393T>C (human) |
CTD ClinVar |
PMID:17062894 PMID:25741868, PMID:17062894 |
RGD:11568045 |
NCBI chr 3:172,374,957...172,434,988
Ensembl chr 3:172,374,957...172,428,483 Ensembl chr 3:172,374,957...172,428,483
|
|
G |
Gnb3 |
G protein subunit beta 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15961981 PMID:16141801 |
|
NCBI chr 4:157,352,558...157,359,237
Ensembl chr 4:157,352,372...157,358,262
|
|
G |
Gnpda2 |
glucosamine-6-phosphate deaminase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19079261 |
|
NCBI chr14:62,628,102...62,646,158
Ensembl chr14:62,628,111...62,646,110
|
|
G |
Got2 |
glutamic-oxaloacetic transaminase 2 |
|
IEP |
protein:increased expression:skeletal muscle tissue, T-tubule (rat) |
RGD |
PMID:23743348 |
RGD:11041118 |
NCBI chr19:9,587,637...9,613,323
Ensembl chr19:9,587,653...9,613,340
|
|
G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
IEP |
mRNA:increased expression:pancreatic islet |
RGD |
PMID:9032096 |
RGD:2313659 |
NCBI chr 1:275,843,823...275,906,880
Ensembl chr 1:275,846,819...275,906,686
|
|
G |
Gpr12 |
G protein-coupled receptor 12 |
|
ISS |
OMIM:601665 |
MouseDO |
|
|
NCBI chr12:10,253,710...10,257,135
Ensembl chr12:10,254,951...10,257,130
|
|
G |
Gpt2 |
glutamic--pyruvic transaminase 2 |
|
ISO |
protein:increased expression, activity:liver: |
RGD |
PMID:25865565 |
RGD:11342811 |
NCBI chr19:22,599,003...22,633,529
Ensembl chr19:22,590,881...22,632,071
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15184668 |
|
NCBI chr 8:117,117,430...117,118,528
Ensembl chr 8:117,117,430...117,118,522
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
|
IEP ISO |
mRNA:decreased expression:adipose tissue (rat) CTD Direct Evidence: marker/mechanism protein:decreased expression, activity:plasma (mouse) |
CTD |
PMID:11328671 PMID:19270708, PMID:19212806, PMID:18562625 |
RGD:2307430, RGD:2312633 |
NCBI chr10:40,247,436...40,255,423
Ensembl chr10:40,247,436...40,255,422
|
|
G |
Gria4 |
glutamate ionotropic receptor AMPA type subunit 4 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
|
|
NCBI chr 8:1,548,145...2,045,874
Ensembl chr 8:1,548,146...2,045,817
|
|
G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
ISO |
mRNA:decreased expression:gonadal fat pad (mouse) |
RGD |
PMID:20150287 |
RGD:5687771 |
NCBI chr 8:85,497,557...85,514,732
Ensembl chr 8:85,497,557...85,518,879
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
|
IEP |
mRNA:decreased expression:liver |
RGD |
PMID:31063713 |
RGD:14701042 |
NCBI chr20:13,799,102...13,816,527
Ensembl chr20:13,799,102...13,816,526
|
|
G |
Gucy2c |
guanylate cyclase 2C |
|
ISS |
OMIM:601665 |
MouseDO |
|
|
NCBI chr 4:170,659,993...170,740,274
Ensembl chr 4:170,659,998...170,740,274
|
|
G |
Hadh |
hydroxyacyl-CoA dehydrogenase |
|
IEP ISO |
protein:increased expression:skeletal muscle CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379, PMID:16088331 |
RGD:2302228 |
NCBI chr 2:236,353,445...236,395,067
Ensembl chr 2:236,353,445...236,395,067
|
|
G |
Hcrt |
hypocretin neuropeptide precursor |
|
IEP |
mRNA:increased expression:perifornical nucleus |
RGD |
PMID:12560202 |
RGD:1358428 |
NCBI chr10:88,669,216...88,670,430
Ensembl chr10:88,669,214...88,670,430
|
|
G |
Hdac4 |
histone deacetylase 4 |
|
ISO |
mRNA,protein:decreased expression:mononuclear cell, adipose tissue: |
RGD |
PMID:24086512 |
RGD:9681453 |
NCBI chr 9:99,052,945...99,299,715
Ensembl chr 9:99,057,089...99,299,715
|
|
G |
Hfe |
homeostatic iron regulator |
|
ISO |
associated with Diabetes Mellitus, Type 2;DNA:missense mutations:CDS:p.C282Y, p.H63D (human) |
RGD |
PMID:10705106 |
RGD:1601449 |
NCBI chr17:43,661,276...43,669,327
Ensembl chr17:43,661,222...43,669,985
|
|
G |
Hgf |
hepatocyte growth factor |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:12706940 |
RGD:1642704 |
NCBI chr 4:15,435,460...15,505,377
Ensembl chr 4:15,433,295...15,505,362
|
|
G |
Hk1 |
hexokinase 1 |
susceptibility |
IDA ISO |
|
RGD |
PMID:12524468, PMID:131232 |
RGD:1601528, RGD:1601527 |
NCBI chr20:31,911,460...31,979,780
Ensembl chr20:31,912,262...31,956,649
|
|
G |
Hk2 |
hexokinase 2 |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:gastrocnemius |
CTD |
PMID:20882379, PMID:11319725, PMID:16555472 |
RGD:2313227, RGD:1624365 |
NCBI chr 4:113,559,396...113,609,897
Ensembl chr 4:113,559,427...113,610,243
|
|
G |
Hmga2 |
high mobility group AT-hook 2 |
|
ISO |
|
RGD |
PMID:10742101 |
RGD:1601569 |
NCBI chr 7:65,159,944...65,275,408
Ensembl chr 7:65,159,944...65,275,408
|
|
G |
Hmgb2 |
high mobility group box 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr16:36,077,615...36,080,191
Ensembl chr16:36,077,617...36,080,191 Ensembl chr11:36,077,617...36,080,191
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
|
IEP |
protein:decreased activity:liver (rat) |
RGD |
PMID:1685984 |
RGD:2326155 |
NCBI chr 2:52,427,351...52,445,082
Ensembl chr 2:52,431,601...52,445,055
|
|
G |
Hmox1 |
heme oxygenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18334666 PMID:18375438 PMID:19171794 |
|
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
|
|
G |
Hoxb5 |
homeo box B5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22484627 |
|
NCBI chr10:84,152,152...84,154,360
Ensembl chr10:84,152,152...84,154,360
|
|
G |
Hp |
haptoglobin |
treatment |
ISO IDA IEP |
protein:increased expression:serum mRNA:increased expression:white fat |
RGD |
PMID:15181041, PMID:19917068, PMID:17161237, PMID:11807829 |
RGD:1626346, RGD:9685197, RGD:1626339, RGD:1626349 |
NCBI chr19:42,096,255...42,100,805
Ensembl chr19:42,097,995...42,100,804
|
|
G |
Hrh3 |
histamine receptor H3 |
|
IDA |
|
RGD |
PMID:17189541 |
RGD:1626405 |
NCBI chr 3:175,474,310...175,479,395
Ensembl chr 3:175,473,078...175,479,395
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
|
IDA ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17628001 PMID:21786805, PMID:15131764, PMID:15118671, PMID:16914598 |
RGD:1625073, RGD:1331525, RGD:1625071 |
NCBI chr13:111,946,626...111,996,536
Ensembl chr13:111,926,442...111,972,603
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
resistance |
ISO IEP |
from transgenic mice expressing human HSD11B2 mRNA:increased expression:adipose tissue:subcutaneous not retroperitoneal fat |
RGD |
PMID:15793240, PMID:17208436 |
RGD:1625083, RGD:1625081 |
NCBI chr19:37,476,083...37,481,326
Ensembl chr19:37,476,095...37,481,307
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
|
ISO |
DNA:SNP:CDS:homozygous P2/P2 allele at position 1267 (p<0.000001) |
RGD |
PMID:11319647 |
RGD:1626642 |
NCBI chr20:4,877,638...4,880,112
Ensembl chr20:2,699,712...2,701,815
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:26655953 |
|
NCBI chr 3:13,838,304...13,842,763
Ensembl chr 3:13,838,304...13,842,762
|
|
G |
Htr1b |
5-hydroxytryptamine receptor 1B |
|
IEP |
protein:increase expression:arcuate nucleus |
RGD |
PMID:10564740 |
RGD:1626450 |
NCBI chr 8:89,113,984...89,130,830
Ensembl chr 8:89,129,453...89,130,991
|
|
G |
Htr2a |
5-hydroxytryptamine receptor 2A |
susceptibility no_association |
ISO |
DNA:polymorphism:promoter:-1438G>A CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:16491645 PMID:17097612, PMID:16328014, PMID:16491645 |
RGD:1624369, RGD:1624370, RGD:1624369 |
NCBI chr15:56,666,152...56,732,469
Ensembl chr15:56,666,012...56,735,382
|
|
G |
Htr2c |
5-hydroxytryptamine receptor 2C |
susceptibility |
ISO |
DNA:polymorphism:promoter:-759C>T CTD Direct Evidence: marker/mechanism associated with Schizophrenia and Psychotic Disorders;DNA:polymorphisms:promoter:multiple |
CTD |
PMID:17702092 PMID:19142110, PMID:15048662, PMID:17016522 |
RGD:1624991, RGD:1624982 |
NCBI chr X:118,084,520...118,318,040
Ensembl chr X:118,084,890...118,318,039
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO IEP |
protein:increased secretion:plasma (human) CTD Direct Evidence: marker/mechanism protein:increased expression:submandibular gland (rat) |
CTD |
PMID:11782876, PMID:20004360, PMID:20973827 |
RGD:4145463, RGD:4145329 |
NCBI chr 8:22,035,287...22,047,049
Ensembl chr 8:22,035,256...22,047,059
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
|
ISO |
|
RGD |
PMID:14969338 |
RGD:1626475 |
NCBI chr 9:71,882,108...71,911,645
Ensembl chr 9:71,882,105...71,900,044
|
|
G |
Ido1 |
indoleamine 2,3-dioxygenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27020609 |
|
NCBI chr16:72,216,326...72,228,098
Ensembl chr16:72,216,326...72,228,098
|
|
G |
Ifng |
interferon gamma |
|
IEP |
associated with Asthma;protein:increased expression:serum |
RGD |
PMID:19575934 |
RGD:2311494 |
NCBI chr 7:61,337,383...61,341,419
Ensembl chr 7:61,337,381...61,341,419
|
|
G |
Igf1r |
insulin-like growth factor 1 receptor |
|
IEP |
mRNA:decreased expression:heart (rat) |
RGD |
PMID:11009458 |
RGD:12904882 |
NCBI chr 1:128,924,921...129,213,816
Ensembl chr 1:128,924,966...129,206,516
|
|
G |
Igf2 |
insulin-like growth factor 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11528401 |
|
NCBI chr 1:215,828,102...215,839,081
Ensembl chr 1:215,828,102...215,846,911
|
|
G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:22537059, PMID:17259371, PMID:17426323 |
RGD:1626479, RGD:1626478 |
NCBI chr 9:80,118,029...80,144,804
Ensembl chr 9:80,118,029...80,144,789
|
|
G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
IEP |
mRNA, protein:decreased expression:pancreatic fat pad |
RGD |
PMID:22067319 |
RGD:10402755 |
NCBI chr14:87,457,647...87,465,374
Ensembl chr14:87,457,647...87,465,374
|
|
G |
Igfbp6 |
insulin-like growth factor binding protein 6 |
|
ISO |
human transgene overexpressed in mouse brain |
RGD |
PMID:15889232 |
RGD:2301717 |
NCBI chr 7:143,749,385...143,754,018
Ensembl chr 7:143,749,221...143,754,054
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
|
ISO |
protein:increased expression:liver: |
RGD |
PMID:15685173 |
RGD:10045952 |
NCBI chr16:74,177,233...74,230,809
Ensembl chr16:74,177,215...74,230,815
|
|
G |
Il10 |
interleukin 10 |
|
IEP ISO |
protein:increase expression:serum |
RGD |
PMID:18787467, PMID:28843383 |
RGD:2308945, RGD:14975146 |
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
|
|
G |
Il15 |
interleukin 15 |
|
ISO |
mRNA, protein:altered expression:skeletal muscle, plasma |
RGD |
PMID:18697873 |
RGD:2313573 |
NCBI chr19:23,542,606...23,624,366
Ensembl chr19:23,542,889...23,554,594
|
|
G |
Il18 |
interleukin 18 |
treatment |
IEP ISO |
|
RGD |
PMID:20490358, PMID:16732281 |
RGD:7175343, RGD:14695532 |
NCBI chr 8:55,009,666...55,016,286
Ensembl chr 8:54,993,859...55,016,299
|
|
G |
Il1b |
interleukin 1 beta |
treatment |
ISO IEP |
protein:increased expression:kidney (rat) protein:increased expression:plasma (mouse) |
RGD |
PMID:16567518, PMID:28843383, PMID:24146106, PMID:20490358, PMID:23150506 |
RGD:1626637, RGD:14975146, RGD:10450599, RGD:7175343, RGD:7175086 |
NCBI chr 3:121,876,256...121,882,637
Ensembl chr 3:121,876,263...121,882,726
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
mRNA, protein:increased expression:adipose tissue |
RGD |
PMID:12975454, PMID:12716739 |
RGD:1626664, RGD:1626665 |
NCBI chr 3:1,449,778...1,468,624
Ensembl chr 3:1,452,644...1,468,614
|
|
G |
Il3 |
interleukin 3 |
|
ISO |
protein: decreased expression: plasma |
RGD |
PMID:21203453 |
RGD:5686875 |
NCBI chr10:39,620,535...39,622,973
Ensembl chr10:39,620,563...39,622,973
|
|
G |
Il6 |
interleukin 6 |
|
ISO IEP |
CTD Direct Evidence: marker/mechanism mRNA:increased expression:islet of Langerhans associated with Diabetes Mellitus, Non-Insulin-Dependent; protein:increased expression:extracellular space (human) |
CTD |
PMID:20141834 PMID:24042701, PMID:16493118, PMID:21826222, PMID:19228869 |
RGD:1601582, RGD:10402828, RGD:2307257 |
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
|
|
G |
Il6r |
interleukin 6 receptor |
susceptibility |
ISO |
DNA:duplication DNA:SNP, haplotypes:promoter:-208G>A (rs4845617) (human) DNA:polymorphism: :p.D358A protein:increased expression:serum |
RGD |
PMID:12917504, PMID:17984249, PMID:16817825, PMID:17434052 |
RGD:1625428, RGD:10402807, RGD:1625430, RGD:1625429 |
NCBI chr 2:189,196,180...189,255,987
Ensembl chr 2:189,205,701...189,254,628
|
|
G |
Il7 |
interleukin 7 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:20376352 |
|
NCBI chr 2:96,427,884...96,474,979
Ensembl chr 2:96,439,286...96,474,977
|
|
G |
Inpp5e |
inositol polyphosphate-5-phosphatase E |
treatment |
ISO IEP |
CTD Direct Evidence: marker/mechanism protein:increased expression:skeletal muscle, white adipose tissue |
CTD |
PMID:19668215, PMID:23349329, PMID:23349329 |
RGD:12911211, RGD:12911211 |
NCBI chr 3:3,843,307...3,856,154
Ensembl chr 3:3,843,307...3,855,981
|
|
G |
Inppl1 |
inositol polyphosphate phosphatase-like 1 |
|
ISO |
DNA:SNPs: :rs2276047,snp8,rs9886(human) |
RGD |
PMID:15220217 |
RGD:1626127 |
NCBI chr 1:166,898,177...166,912,524
Ensembl chr 1:166,899,894...166,912,524
|
|
G |
Ins2 |
insulin 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:2777199 PMID:8923850 PMID:11528401 PMID:29035695 |
|
NCBI chr 1:215,856,967...215,858,034
Ensembl chr 1:215,856,971...215,858,034
|
|
G |
Irs1 |
insulin receptor substrate 1 |
|
IDA ISO |
protein:decreased tyrosine phosphorylation, increased serine phosphorylation:skeletal muscle CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23954404, PMID:22982470 |
RGD:7207062 |
NCBI chr 9:88,033,668...88,086,488
Ensembl chr 9:88,033,668...88,086,488
|
|
G |
Irs2 |
insulin receptor substrate 2 |
|
ISO |
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr16:83,824,515...83,848,569
Ensembl chr16:83,824,430...83,848,684
|
|
G |
Itgam |
integrin subunit alpha M |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29035695 |
|
NCBI chr 1:199,495,312...199,545,738
Ensembl chr 1:199,495,298...199,623,960
|
|
G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain 4 |
|
IEP |
|
RGD |
PMID:22134356 |
RGD:11352709 |
NCBI chr16:6,970,367...6,985,538
Ensembl chr16:6,970,342...6,985,579
|
|
G |
Jak2 |
Janus kinase 2 |
|
ISO IEP |
protein:decreased expression:hypothalamus |
RGD |
PMID:14630696, PMID:23397595 |
RGD:1627661, RGD:10411893 |
NCBI chr 1:247,398,667...247,457,521
Ensembl chr 1:247,398,598...247,458,509
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:7889573 PMID:9024139 PMID:9927399 PMID:10753933 PMID:10973849 PMID:11113008 PMID:11468227 PMID:11668638 PMID:11854117 PMID:12354768 PMID:15051636 PMID:15840476 PMID:16432067 PMID:17160940 PMID:17445409 PMID:18441445 PMID:18593567 PMID:19716085 PMID:19841300 PMID:22581653 PMID:22949429 PMID:23303164 PMID:24606995 PMID:24623279 PMID:25741868 PMID:26847485 PMID:28492532 PMID:29672598 PMID:30246897 |
|
NCBI chr 4:7,355,066...7,387,282
Ensembl chr 4:7,355,574...7,387,253
|
|
G |
Kcnma1 |
potassium calcium-activated channel subfamily M alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27605626 |
|
NCBI chr15:344,204...1,048,849
Ensembl chr15:344,360...1,047,956
|
|
G |
Kctd15 |
potassium channel tetramerization domain containing 15 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19079261 |
|
NCBI chr 1:90,506,697...90,522,217
Ensembl chr 1:90,506,697...90,520,344
|
|
G |
Kdm3a |
lysine demethylase 3A |
|
ISO ISS |
OMIM:601665 |
MouseDO |
PMID:19875498 |
RGD:9590220 |
NCBI chr 4:99,503,160...99,547,315
Ensembl chr 4:99,503,176...99,546,905
|
|
G |
Kif4a |
kinesin family member 4A |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:25741868 |
|
NCBI chr X:70,461,700...70,561,084
Ensembl chr X:70,461,718...70,561,189
|
|
G |
Kitlg |
KIT ligand |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23954404 |
|
NCBI chr 7:42,269,784...42,351,054
Ensembl chr 7:42,269,784...42,351,054
|
|
G |
Lactb |
lactamase, beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18344982 |
|
NCBI chr 8:72,750,174...72,766,307
Ensembl chr 8:72,750,171...72,766,389
|
|
G |
Lbp |
lipopolysaccharide binding protein |
treatment |
IDA ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23349936, PMID:19917068 |
RGD:9685197 |
NCBI chr 3:154,786,232...154,812,910
Ensembl chr 3:154,786,215...154,813,464
|
|
G |
Lcn2 |
lipocalin 2 |
|
IEP |
mRNA:increased expression:epididymal fat pad, adipose cell (rat) |
RGD |
PMID:18292240 |
RGD:2316514 |
NCBI chr 3:11,414,189...11,417,534
Ensembl chr 3:11,414,186...11,417,546
|
|
G |
Ldlr |
low density lipoprotein receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25554529, PMID:15118671 |
RGD:1331525 |
NCBI chr 8:22,750,425...22,773,305
Ensembl chr 8:22,750,336...22,774,903
|
|
G |
Lep |
leptin |
treatment no_association |
IEP ISO IMP IDA |
protein:increased expression:serum CTD Direct Evidence: marker/mechanism|therapeutic ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity DNA:nonsense mutation:cds: mouse protein in a rat model |
CTD ClinVar |
PMID:9202122 PMID:9502777 PMID:9826672 PMID:17517446 PMID:18515891 PMID:19913045 PMID:20122948 PMID:23839791 PMID:24042701 PMID:25086370 PMID:25551525 PMID:25554529 PMID:25741868 PMID:26186301 PMID:28492532 PMID:28698385 PMID:31313498, PMID:21075806, PMID:22948215, PMID:23800849, PMID:23793169, PMID:10029567, PMID:7624776, PMID:15118671, PMID:15910756, PMID:19267279, PMID:19726711 |
RGD:5128551, RGD:12904911, RGD:8549777, RGD:10053638, RGD:10053612, RGD:2311134, RGD:1331525, RGD:1643130, RGD:2311132, RGD:5128629 |
NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
|
|
G |
Lepem1Sage |
leptin; zinc finger nuclease induced mutant1, Sage |
|
IMP |
|
RGD |
PMID:22948215 |
RGD:12904911 |
|
|
G |
Lepm1Kyo |
leptin; ENU induced mutant1, Kyo |
|
IMP |
|
RGD |
PMID:23800849 |
RGD:8549777 |
|
|
G |
Lepr |
leptin receptor |
disease_progression sexual_dimorphism no_association treatment susceptibility |
ISO IMP IAGP |
mRNA:decreased expression:lung compared to BN compared to heterozygous controls +/fa compared to age-matched lean +/fa rats CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity protein:increased expression:hippocampus,astrocyte: ClinVar Annotator: match by null DNA:missense mutation: :p.Q269P (rat) DNA:polymorphism:exon:p.Q223R (human) |
CTD ClinVar |
PMID:3519326 PMID:8666155 PMID:11354636 PMID:11380591 PMID:11443193 PMID:12006639 PMID:17065336 PMID:17229951 PMID:17785359 PMID:18490929 PMID:19913045 PMID:20567778 PMID:21393862 PMID:21744741 PMID:22276206 PMID:22331430 PMID:23563609 PMID:24263156 PMID:25222487 PMID:25741868 PMID:26467025 PMID:28492532 PMID:29743445 PMID:30689673 PMID:30993381, PMID:20592105, PMID:27465994, PMID:27225180, PMID:20159938, PMID:11500530, PMID:9843879, PMID:27465994, PMID:22693203, PMID:9545018, PMID:16284652, PMID:24785100, PMID:15118671, PMID:8702432, PMID:18204169, PMID:8841178 |
RGD:5129154, RGD:12911217, RGD:12910507, RGD:7365117, RGD:628581, RGD:628910, RGD:12911217, RGD:10412038, RGD:10412023, RGD:10412018, RGD:10411891, RGD:1331525, RGD:729297, RGD:5128855, RGD:1600612 |
NCBI chr 5:120,503,475...120,682,281
Ensembl chr 5:120,564,645...120,682,221
|
|
G |
Leprem2 |
leptin receptor; TALEN induced mutant 2 |
|
IMP |
|
RGD |
PMID:27225180 |
RGD:12910507 |
|
|
G |
Leprem2Mcwi |
leptin receptor; zinc finger nuclease induced mutant 2, Medical College of Wisconsin |
disease_progression |
IMP |
|
RGD |
PMID:27465994, PMID:27465994 |
RGD:12911217, RGD:12911217 |
|
|
G |
Leprem3 |
leptin receptor; TALEN induced mutant 3 |
|
IMP |
|
RGD |
PMID:27225180 |
RGD:12910507 |
|
|
G |
Leprfa |
leptin receptor; fa mutant |
sexual_dimorphism |
IAGP |
compared to BN compared to age-matched lean +/fa rats compared to heterozygous controls +/fa |
RGD |
PMID:20159938, PMID:9843879, PMID:11500530 |
RGD:7365117, RGD:628910, RGD:628581 |
|
|
G |
Leprot |
leptin receptor overlapping transcript |
|
ISO |
ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity |
ClinVar |
PMID:28492532 |
|
NCBI chr 5:120,498,910...120,511,011
Ensembl chr 5:120,498,883...120,511,017
|
|
G |
Lipc |
lipase C, hepatic type |
|
ISO IAGP |
associated with Diabetes Mellitus, Insulin-Dependent; protein:increased expression:plasma (human) protein:altered expression:liver, plasma (rat) |
RGD |
PMID:12843191, PMID:11544558 |
RGD:2308835, RGD:2308784 |
NCBI chr 8:77,272,582...77,398,485
Ensembl chr 8:77,272,570...77,398,248
|
|
G |
Lipe |
lipase E, hormone sensitive type |
|
IEP |
mRNA:decreased expression:white fat |
RGD |
PMID:17712951 |
RGD:2313580 |
NCBI chr 1:82,248,031...82,266,727
Ensembl chr 1:82,248,046...82,266,727
|
|
G |
Lipg |
lipase G, endothelial type |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:16772345 |
RGD:1641819 |
NCBI chr18:70,903,528...70,924,434
Ensembl chr18:70,901,710...70,924,708
|
|
G |
LOC100909544 |
bromodomain-containing protein 2-like |
|
ISO |
|
RGD |
PMID:19883376 |
RGD:9586446 |
NCBI chr20:3,910,555...3,918,348
Ensembl chr20:3,910,555...3,917,426
|
|
G |
LOC103690091 |
proSAAS |
|
ISO |
protein:increased expression:brainstem |
RGD |
PMID:11680901 |
RGD:1642351 |
NCBI chr X:15,324,261...15,328,617
|
|
G |
Lpl |
lipoprotein lipase |
treatment |
IEP IDA ISO |
mRNA:increased expression:white fat CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18344982, PMID:17712951, PMID:27160499, PMID:28514832, PMID:18952837 |
RGD:2313580, RGD:13794378, RGD:13793401, RGD:2313300 |
NCBI chr16:22,537,687...22,561,487
Ensembl chr16:22,537,056...22,561,496
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
|
ISO |
protein:increased phosphorylation:endometrium (human) |
RGD |
PMID:20074784 |
RGD:13782055 |
NCBI chr11:88,203,863...88,273,301
Ensembl chr11:88,211,599...88,273,254
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
|
ISO |
protein:increased phosphorylation:endometrium (human) |
RGD |
PMID:20074784 |
RGD:13782055 |
NCBI chr 1:198,192,773...198,198,975
Ensembl chr 1:198,192,773...198,198,975
|
|
G |
Mapt |
microtubule-associated protein tau |
|
IDA |
|
RGD |
PMID:25257559 |
RGD:13800921 |
NCBI chr10:92,289,002...92,386,517
Ensembl chr10:92,288,910...92,386,517
|
|
G |
Mbl1 |
mannose binding lectin 1 |
|
ISO |
protein:decreased secretion:plasma (mouse) |
RGD |
PMID:16955210 |
RGD:4889156 |
NCBI chr16:18,736,154...18,742,193
Ensembl chr16:18,736,154...18,742,193
|
|
G |
Mbl2 |
mannose binding lectin 2 |
|
ISO |
DNA:missense mutations:cds:p.R52C, p.G57E (human) |
RGD |
PMID:16955210 |
RGD:4889156 |
NCBI chr 1:248,435,069...248,442,669
Ensembl chr 1:248,723,397...248,729,962
|
|
G |
Mc3r |
melanocortin 3 receptor |
susceptibility |
ISO |
DNA:point mutation:I183N CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Body mass index quantitative trait locus 9 DNA:missense mutations:cds:p.T6K, p.V81I (human) |
CTD OMIM ClinVar |
PMID:11889220 PMID:15276649 PMID:15292330 PMID:18231126 PMID:21047972, PMID:11889220, PMID:16123355, PMID:15118671 |
RGD:1625178, RGD:6484587, RGD:1331525 |
NCBI chr 3:170,252,901...170,253,998
Ensembl chr 3:170,252,901...170,253,998
|
|
G |
Mc4r |
melanocortin 4 receptor |
|
ISO IEP IMP |
ClinVar Annotator: match by term: Obesity ClinVar Annotator: match by term: Obesity, autosomal dominant CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by OMIM:601665 mRNA:decreased expression:hypothalamus (rat) DNA:nonsense mutation:cds:p.K314X (rat) |
ClinVar CTD |
PMID:9267995 PMID:10078568 PMID:10199800 PMID:10577903 PMID:10592235 PMID:10903341 PMID:10903343 PMID:11443223 PMID:12364414 PMID:12364415 PMID:12499395 PMID:12588803 PMID:12629567 PMID:12646665 PMID:12646666 PMID:12690102 PMID:12851297 PMID:12959994 PMID:12970296 PMID:14633862 PMID:14764812 PMID:14764818 PMID:14973783 PMID:15037865 PMID:15126516 PMID:15448103 PMID:15466016 PMID:15486053 PMID:15585384 PMID:15805150 PMID:15975705 PMID:16030156 PMID:16032553 PMID:16083993 PMID:16094248 PMID:16231025 PMID:16274851 PMID:16289450 PMID:16469222 PMID:16492696 PMID:16507637 PMID:16611215 PMID:16614075 PMID:16616374 PMID:16710097 PMID:16752916 PMID:16960181 PMID:17143585 PMID:17185898 PMID:17286227 PMID:17306938 PMID:17357083 PMID:17492953 PMID:17517246 PMID:17519222 PMID:17579204 PMID:17628007 PMID:17668051 PMID:17986382 PMID:18454148 PMID:18559663 PMID:18801902 PMID:18997677 PMID:19011902 PMID:19079260 PMID:19079261 PMID:19091795 PMID:19151714 PMID:19179454 PMID:19184404 PMID:19244934 PMID:19284607 PMID:19298524 PMID:19301229 PMID:19400288 PMID:19417090 PMID:19766264 PMID:20462274 PMID:20631012 PMID:20696697 PMID:20826565 PMID:20966905 PMID:20975296 PMID:21085626 PMID:21404042 PMID:22106157 PMID:22447289 PMID:22463805 PMID:22688572 PMID:23146882 PMID:23251400 PMID:23505181 PMID:23791567 PMID:24276017 PMID:24385306 PMID:24512492 PMID:24611737 PMID:24705671 PMID:24780838 PMID:24890885 PMID:25076858 PMID:25136332 PMID:25332687 PMID:25741868 PMID:26047380 PMID:26179253 PMID:26238496 PMID:26244670 PMID:26467025 PMID:26588347 PMID:26666384 PMID:26782456 PMID:26788538 PMID:27222505 PMID:27654141 PMID:28492532 PMID:29273807 PMID:29758564 PMID:29861388 PMID:29970488 PMID:30004997 PMID:30048591 PMID:31002796, PMID:12646665, PMID:21779089, PMID:9019399, PMID:21527895, PMID:15118671 |
RGD:1600756, RGD:6484210, RGD:6484144, RGD:6478803, RGD:1331525 |
NCBI chr18:62,612,838...62,614,725
Ensembl chr18:62,612,838...62,614,725
|
|
G |
Mc4rm1Hubr |
melanocortin 4 receptor; ENU induced mutation 1, Hubr |
|
IMP |
|
RGD |
PMID:21527895 |
RGD:6478803 |
|
|
G |
Mchr1 |
melanin-concentrating hormone receptor 1 |
|
IEP |
mRNA:increased expression:hypothalamus |
RGD |
PMID:15363890 |
RGD:1624360 |
NCBI chr 7:122,456,846...122,459,324
Ensembl chr 7:122,456,799...122,459,960
|
|
G |
Me1 |
malic enzyme 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19270708 |
|
NCBI chr 8:94,256,830...94,368,834
Ensembl chr 8:94,256,839...94,368,834
|
|
G |
Mfn2 |
mitofusin 2 |
|
ISO IEP |
mRNA:decreased expression:skeletal muscle tissue (human) mRNA:decreased expression:liver (rat) |
RGD |
PMID:12598526, PMID:25336449 |
RGD:1601412, RGD:12880438 |
NCBI chr 5:164,684,244...164,715,414
Ensembl chr 5:164,684,509...164,714,145
|
|
G |
Mgrn1 |
mahogunin ring finger 1 |
|
ISO |
|
RGD |
PMID:16638826 |
RGD:1641947 |
NCBI chr10:10,832,573...10,881,999
Ensembl chr10:10,833,519...10,881,977
|
|
G |
Mif |
macrophage migration inhibitory factor |
|
ISO |
DNA:polymorphisms:promoter mRNA, protein:increased expression:mononuclear cell, plasma |
RGD |
PMID:16247506, PMID:15472203 |
RGD:1641950, RGD:1641953 |
NCBI chr20:13,715,219...13,732,980
Ensembl chr20:13,732,198...13,732,859
|
|
G |
Mir107 |
microRNA 107 |
|
ISO |
RNA:decreased expression:liver: |
RGD |
PMID:21120623 |
RGD:14975298 |
NCBI chr 1:253,128,250...253,128,336
Ensembl chr 1:253,128,250...253,128,336
|
|
G |
Mir125a |
microRNA 125a |
|
ISO |
|
RGD |
PMID:31988048 |
RGD:21403676 |
NCBI chr 1:59,704,827...59,704,911
Ensembl chr 1:59,704,827...59,704,911
|
|
G |
Mir130a |
microRNA 130a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28242765 |
|
NCBI chr 3:72,141,037...72,141,124
Ensembl chr 3:72,141,037...72,141,124
|
|
G |
Mir130b |
microRNA 130b |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28242765 |
|
NCBI chr11:88,129,773...88,129,854
Ensembl chr11:88,129,773...88,129,854
|
|
G |
Mir155 |
microRNA 155 |
|
ISO |
miRNA:decreased expression:serum |
RGD |
PMID:28970282, PMID:29479888, PMID:27856635 |
RGD:21079445, RGD:24922220, RGD:21079446 |
NCBI chr11:24,176,603...24,176,667
Ensembl chr11:24,176,603...24,176,667
|
|
G |
Mir184 |
microRNA 184 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23954404 |
|
NCBI chr 8:97,175,657...97,175,733
Ensembl chr 8:97,175,657...97,175,733
|
|
G |
Mir21 |
microRNA 21 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23954404 |
|
NCBI chr10:73,902,210...73,902,301
Ensembl chr10:73,902,210...73,902,301
|
|
G |
Mir223 |
microRNA 223 |
|
ISO |
RNA:increased expression:pancreatic islet |
RGD |
PMID:31118273 |
RGD:25823139 |
NCBI chr X:65,367,812...65,367,921
Ensembl chr X:65,367,812...65,367,921
|
|
G |
Mir34a |
microRNA 34a |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23834033 |
|
NCBI chr 5:167,092,491...167,092,592
Ensembl chr 5:167,092,491...167,092,592
|
|
G |
Mkks |
McKusick-Kaufman syndrome |
no_association |
ISO ISS |
OMIM:601665 |
MouseDO |
PMID:15483080, PMID:10973251 |
RGD:1601414, RGD:1581208 |
NCBI chr 3:129,866,542...129,885,213
Ensembl chr 3:129,866,545...129,884,810
|
|
G |
Mmp19 |
matrix metallopeptidase 19 |
|
ISO |
mRNA:increased expression:adipose tissue |
RGD |
PMID:15169894, PMID:12529376 |
RGD:1642022, RGD:1642023 |
NCBI chr 7:3,216,392...3,224,202
Ensembl chr 7:3,216,497...3,224,201
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
|
ISO |
protein:increased expression:plasma CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21156398, PMID:17512313 |
RGD:1642026 |
NCBI chr 3:161,413,410...161,421,473
Ensembl chr 3:161,413,298...161,421,520
|
|
G |
Mmut |
methylmalonyl-CoA mutase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 9:23,323,934...23,352,144
Ensembl chr 9:23,323,936...23,352,668
|
|
G |
Mrap2 |
melanocortin 2 receptor accessory protein 2 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Obesity CTD Direct Evidence: marker/mechanism |
ClinVar CTD OMIM |
PMID:23869016 |
|
NCBI chr 8:94,801,336...94,858,192
Ensembl chr 8:94,801,336...94,857,443
|
|
G |
Mrc1 |
mannose receptor, C type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29035695 |
|
NCBI chr17:81,352,700...81,433,743
Ensembl chr17:81,352,700...81,433,743
|
|
G |
Mt-cyb |
mitochondrially encoded cytochrome b |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:12905068 PMID:25741868 |
|
NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
|
|
G |
Mt-nd1 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1 |
|
ISO |
DNA:missense mutation: :p.A64V (human) |
RGD |
PMID:16060290 |
RGD:2300401 |
NCBI chr MT:2,740...3,694
Ensembl chr MT:2,740...3,694
|
|
G |
Mt3 |
metallothionein 3 |
|
ISO |
|
RGD |
PMID:21726645 |
RGD:6480475 |
NCBI chr19:11,324,708...11,326,112
Ensembl chr19:11,324,698...11,326,139
|
|
G |
Mtch2 |
mitochondrial carrier 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19079261 |
|
NCBI chr 3:79,678,141...79,695,356
Ensembl chr 3:79,678,201...79,694,006
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
|
IEP |
mRNA, protein:decreased expression:hypothalamus |
RGD |
PMID:25807795 |
RGD:11570513 |
NCBI chr 5:165,263,813...165,373,967
Ensembl chr 5:165,263,800...165,373,967
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
susceptibility |
ISO |
DNA:polymorphisms |
RGD |
PMID:15635487, PMID:15635487 |
RGD:1625486, RGD:1625486 |
NCBI chr 2:243,366,181...243,407,608
Ensembl chr 2:243,366,181...243,407,608
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
|
IEP |
mRNA:decreased expression:pancreas (rat) |
RGD |
PMID:22421529 |
RGD:7240547 |
NCBI chr 7:102,586,313...102,591,240
Ensembl chr 7:102,586,313...102,591,240
|
|
G |
Myh9 |
myosin, heavy chain 9 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:25741868 PMID:31064749 |
|
NCBI chr 7:118,740,005...118,792,507
Ensembl chr 7:118,741,110...118,792,625
|
|
G |
Myod1 |
myogenic differentiation 1 |
|
IEP |
mRNA:decreased expression:plantaris |
RGD |
PMID:22349736, PMID:18508911 |
RGD:9686079, RGD:2313320 |
NCBI chr 1:102,396,538...102,399,248
Ensembl chr 1:102,396,538...102,399,248
|
|
G |
Myog |
myogenin |
|
IEP |
mRNA:decreased expression:plantaris |
RGD |
PMID:18508911 |
RGD:2313320 |
NCBI chr13:51,126,459...51,129,048
Ensembl chr13:51,126,459...51,129,048
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
|
ISO |
protein:increased expression:serum CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23834033, PMID:17618961 |
RGD:1642336 |
NCBI chr 6:52,122,085...52,156,473
Ensembl chr 6:52,122,085...52,156,472
|
|
G |
Ncf2 |
neutrophil cytosolic factor 2 |
|
IEP |
protein:increased expression:artery |
RGD |
PMID:17515452 |
RGD:2314435 |
NCBI chr13:70,226,441...70,259,019
Ensembl chr13:70,226,647...70,257,576
|
|
G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
ISS |
OMIM:601665 |
MouseDO |
|
|
NCBI chr 6:28,677,563...28,931,844
Ensembl chr 6:28,677,540...28,931,843
|
|
G |
Ncoa3 |
nuclear receptor coactivator 3 |
|
ISO |
|
RGD |
PMID:14557830 |
RGD:1642050 |
NCBI chr 3:162,692,176...162,788,582
Ensembl chr 3:162,692,185...162,787,548
|
|
G |
Ndufb6 |
NADH:ubiquinone oxidoreductase subunit B6 |
|
IEP |
mRNA:decreased expression:epididymal fat pad |
RGD |
PMID:20559011 |
RGD:13822707 |
NCBI chr 5:56,567,109...56,576,676
Ensembl chr 5:56,567,109...56,576,676
|
|
G |
Negr1 |
neuronal growth regulator 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19079261 |
|
NCBI chr 2:262,914,240...263,650,441
Ensembl chr 2:262,914,327...263,650,441
|
|
G |
Neil1 |
nei-like DNA glycosylase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16446448 PMID:21285402 |
|
NCBI chr 8:61,817,258...61,824,023
Ensembl chr 8:61,817,258...61,823,102
|
|
G |
Neurod1 |
neuronal differentiation 1 |
|
ISO |
mRNA:increased expression:pancreas |
RGD |
PMID:15979049 |
RGD:1625044 |
NCBI chr 3:66,414,314...66,417,617
Ensembl chr 3:66,414,308...66,417,741
|
|
G |
Nfe2l2 |
nuclear factor, erythroid 2-like 2 |
|
ISO |
protein:decreased expression:liver macrophage: protein:decreased expression:hepatocyte : |
RGD |
PMID:32102936, PMID:32102936 |
RGD:21201281, RGD:21201281 |
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
|
|
G |
Nhlh2 |
nescient helix loop helix 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20808804 |
|
NCBI chr 2:204,427,577...204,432,946
Ensembl chr 2:204,427,608...204,432,946
|
|
G |
Nmb |
neuromedin B |
susceptibility |
ISO IEP |
protein:increased expression:central hypothalamus:concentrations higher in obese (fa/fa) than in lean (Fa/?) male Zucker rats, not affected by weight loss |
RGD |
PMID:15585758, PMID:11194934, PMID:1709601 |
RGD:1642059, RGD:1642062, RGD:1642063 |
NCBI chr 1:142,721,263...142,724,646
Ensembl chr 1:142,721,002...142,724,511
|
|
G |
Nmu |
neuromedin U |
susceptibility |
IDA ISO |
DNA:polymorphisms:cds:p.R165W,p.A19E |
RGD |
PMID:17706946, PMID:15448684, PMID:16984985 |
RGD:1642093, RGD:1642095, RGD:1642094 |
NCBI chr14:34,353,683...34,381,968
Ensembl chr14:34,354,503...34,381,828
|
|
G |
Nnt |
nicotinamide nucleotide transhydrogenase |
|
IEP |
protein:decreased expression:gastrocnemius, soleus |
RGD |
PMID:25761734 |
RGD:13513980 |
NCBI chr 2:52,189,523...52,283,095
Ensembl chr 2:52,189,529...52,282,548
|
|
G |
Nos1 |
nitric oxide synthase 1 |
|
IEP |
|
RGD |
PMID:16316351 |
RGD:1642132 |
NCBI chr12:44,214,949...44,405,530
Ensembl chr12:44,213,943...44,520,341
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
protein:increased expression:sputum protein:increased expression:liver, gastrocnemius muscle, adipose tissue (mouse) |
RGD |
PMID:18098375, PMID:21896669 |
RGD:4891935, RGD:5509059 |
NCBI chr10:66,188,290...66,221,621
Ensembl chr10:66,189,786...66,313,190
|
|
G |
Nos3 |
nitric oxide synthase 3 |
treatment |
IEP |
protein:decreased expression:artery |
RGD |
PMID:17623751, PMID:29180887 |
RGD:2292133, RGD:13504728 |
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
|
|
G |
Npc1 |
NPC intracellular cholesterol transporter 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19151714 |
|
NCBI chr18:3,616,878...3,662,656
Ensembl chr18:3,616,878...3,662,683
|
|
G |
Nppa |
natriuretic peptide A |
|
ISO |
associated with Heart Failure; |
RGD |
PMID:23566312 |
RGD:7247714 |
NCBI chr 5:164,808,407...164,809,716
Ensembl chr 5:164,808,323...164,809,705
|
|
G |
Nppb |
natriuretic peptide B |
|
ISO IEP |
associated with Diabetes Mellitus, Type 2 mRNA:decreased expression:heart |
RGD |
PMID:21959345, PMID:24009719 |
RGD:5685647, RGD:7327171 |
NCBI chr 5:164,796,176...164,797,538
Ensembl chr 5:164,796,185...164,797,531
|
|
G |
Npy |
neuropeptide Y |
|
IEP |
mRNA, protein:increased expression:hypothalamus |
RGD |
PMID:17447163 |
RGD:10448938 |
NCBI chr 4:79,557,856...79,565,059
Ensembl chr 4:79,557,854...79,565,097
|
|
G |
Npy1r |
neuropeptide Y receptor Y1 |
susceptibility |
ISO IEP |
associated with Hyperinsulinemia CTD Direct Evidence: marker/mechanism mRNA:increased expression:hypothalamus |
CTD |
PMID:20975297, PMID:9861026, PMID:17447163 |
RGD:1642306, RGD:10448938 |
NCBI chr16:24,779,480...24,789,131
Ensembl chr16:24,779,477...24,788,740
|
|
G |
Npy2r |
neuropeptide Y receptor Y2 |
|
ISO IEP |
mRNA:increased expression:hypothalamus |
RGD |
PMID:17019604, PMID:17447163 |
RGD:1642379, RGD:10448938 |
NCBI chr 2:181,528,949...181,538,145
Ensembl chr 2:181,530,832...181,531,978
|
|
G |
Npy5r |
neuropeptide Y receptor Y5 |
susceptibility |
ISO IEP |
DNA:polymorphisms CTD Direct Evidence: marker/mechanism mRNA:increased expression:hypothalamus |
CTD |
PMID:10849579, PMID:10849579, PMID:17447163, PMID:15118671 |
RGD:1625493, RGD:10448938, RGD:1331525 |
NCBI chr16:24,796,685...24,805,730
Ensembl chr16:24,797,124...24,805,079
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17405841 |
|
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
|
ISO |
ClinVar Annotator: match by term: Obesity, mild, early-onset |
ClinVar OMIM |
PMID:11136233, PMID:11136233 |
RGD:1600912 |
NCBI chr 5:151,776,004...151,779,319
Ensembl chr 5:151,776,004...151,779,319
|
|
G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
disease_progression |
ISO IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:17108812, PMID:25612518, PMID:20939869 |
RGD:1626248, RGD:15045599, RGD:13506790 |
NCBI chr 1:100,554,577...100,559,896
Ensembl chr 1:100,554,544...100,559,942
|
|
G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
disease_progression |
ISO IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:17108812, PMID:25612518 |
RGD:1626248, RGD:15045599 |
NCBI chr 3:80,004,130...80,014,197
Ensembl chr 3:80,004,130...80,012,750
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
disease_progression |
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:25612518 |
RGD:15045599 |
NCBI chr 7:30,003,429...30,162,095
Ensembl chr 7:30,003,429...30,162,056
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20869355 |
|
NCBI chr11:65,022,100...65,058,546
Ensembl chr11:65,022,100...65,058,545
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20869355 |
|
NCBI chr13:89,585,072...89,591,278
Ensembl chr13:89,586,283...89,591,277
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
no_association |
IDA ISO |
associated with Depressive Disorder, Major;DNA:SNP:intron:IVS2+646C>G (human) |
RGD GAD |
PMID:20723946, PMID:18246526, PMID:15118671, PMID:16725041 |
RGD:4892206, RGD:7174717, RGD:1331525, RGD:1601498 |
NCBI chr18:31,728,373...32,704,022
Ensembl chr18:31,728,373...31,749,647
|
|
G |
Nrxn1 |
neurexin 1 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
|
|
NCBI chr 6:13,886,757...15,191,660
Ensembl chr 6:13,886,740...15,191,660
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Obesity |
CTD ClinVar |
PMID:15494731 |
|
NCBI chr17:5,934,651...6,245,778
Ensembl chr17:5,933,729...6,244,676
|
|
G |
Nucb2 |
nucleobindin 2 |
|
IEP |
protein:increased expression:adipose tissue: |
RGD |
PMID:22641054 |
RGD:9831187 |
NCBI chr 1:185,106,773...185,143,278
Ensembl chr 1:185,104,656...185,143,272
|
|
G |
Nudc |
nuclear distribution C, dynein complex regulator |
|
ISO |
ClinVar Annotator: match by term: Obesity, mild, early-onset |
ClinVar |
PMID:11136233 |
|
NCBI chr 5:151,754,723...151,768,104
Ensembl chr 5:151,754,716...151,768,123
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29709520 |
|
NCBI chr 4:145,282,828...145,289,367
Ensembl chr 4:145,282,797...145,289,326
|
|
G |
Otc |
ornithine transcarbamylase |
|
IEP |
protein:increased activity:liver (rat) |
RGD |
PMID:1330956 |
RGD:4144087 |
NCBI chr X:13,524,804...13,601,074
Ensembl chr X:13,524,607...13,601,069
|
|
G |
Oxct1 |
3-oxoacid CoA transferase 1 |
|
IEP |
mRNA:decreased expression:thalamus (rat) |
RGD |
PMID:19219059 |
RGD:2326191 |
NCBI chr 2:53,859,738...54,007,733
Ensembl chr 2:53,859,737...54,007,756
|
|
G |
Pacs1 |
phosphofurin acidic cluster sorting protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23563609 |
|
NCBI chr 1:220,515,117...220,645,611
Ensembl chr 1:220,516,316...220,644,636
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20561897 |
|
NCBI chr13:98,857,255...98,889,444
Ensembl chr13:98,857,177...98,889,716
|
|
G |
Pax8 |
paired box 8 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:25741868 |
|
NCBI chr 3:1,527,316...1,586,019
Ensembl chr 3:1,527,279...1,584,946
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 3:171,213,936...171,219,885
Ensembl chr 3:171,213,936...171,219,871
|
|
G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
|
ISO |
DNA:missense mutation:cds: p.G483R (human) ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity ClinVar Annotator: match by term: Body mass index quantitative trait locus 12 CTD Direct Evidence: marker/mechanism |
ClinVar CTD |
PMID:18604207 PMID:28492532, PMID:9207799, PMID:15189116 |
RGD:1601274, RGD:1357925 |
NCBI chr 2:91,450,162...91,497,091
Ensembl chr 2:91,450,162...91,497,091
|
|
G |
Pcsk1n |
proprotein convertase subtilisin/kexin type 1 inhibitor |
|
IAGP ISO |
protein:increased expression:brainstem |
RGD |
PMID:15012590, PMID:11680901 |
RGD:1642350, RGD:1642351 |
NCBI chr X:15,324,263...15,327,705
|
|
G |
Pde3a |
phosphodiesterase 3A |
|
IEP |
mRNA:decreased expression:heart |
RGD |
PMID:9648839 |
RGD:2300415 |
NCBI chr 4:175,431,904...175,703,844
Ensembl chr 4:175,431,904...175,700,238
|
|
G |
Pdp1 |
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
|
ISO |
|
RGD |
PMID:15897476 |
RGD:1642637 |
NCBI chr 5:25,577,593...25,584,325
Ensembl chr 5:25,577,451...25,584,288
|
|
G |
Pdx1 |
pancreatic and duodenal homeobox 1 |
|
ISO |
mRNA:increased expression:exocrine pancreas (human) |
RGD |
PMID:15979049 |
RGD:1625044 |
NCBI chr12:9,496,044...9,501,211
Ensembl chr12:9,496,044...9,501,213
|
|
G |
Pex11a |
peroxisomal biogenesis factor 11 alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30585412 |
|
NCBI chr 1:141,474,189...141,481,270
Ensembl chr 1:141,474,180...141,481,315
|
|
G |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr17:70,632,778...70,713,736
Ensembl chr17:70,684,134...70,713,726
|
|
G |
Pgf |
placental growth factor |
|
ISO |
associated with pancreatic cancer;protein:increased expression:plasma (human) associated with Pre-eclampsia;protein:increased expression:serum |
RGD |
PMID:16020476, PMID:26861455, PMID:16769024 |
RGD:1642385, RGD:14349030, RGD:1642384 |
NCBI chr 6:108,994,016...109,004,598
Ensembl chr 6:108,994,018...109,004,598
|
|
G |
Pgr |
progesterone receptor |
|
ISO |
|
RGD |
PMID:14557830 |
RGD:1642050 |
NCBI chr 8:7,128,656...7,187,796
Ensembl chr 8:7,128,656...7,187,796
|
|
G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
|
ISO |
|
RGD |
PMID:21949398 |
RGD:6482700 |
NCBI chr 6:51,465,696...51,501,234
Ensembl chr 6:51,465,908...51,498,337
|
|
G |
Pik3r1 |
phosphoinositide-3-kinase regulatory subunit 1 |
|
IEP ISO |
protein:decreased expression:soleus protein:decreased tyrosine phosphorylation:skeletal muscle, liver |
RGD |
PMID:16123202, PMID:9399964 |
RGD:1625220, RGD:1625218 |
NCBI chr 2:31,742,326...31,826,882
Ensembl chr 2:31,745,088...31,826,867
|
|
G |
Pklr |
pyruvate kinase L/R |
|
ISO |
mRNA, protein:decreased expression:liver |
RGD |
PMID:12958186 |
RGD:1625583 |
NCBI chr 2:188,449,158...188,458,034
Ensembl chr 2:188,449,210...188,459,592
|
|
G |
Plat |
plasminogen activator, tissue type |
|
ISO |
|
RGD |
PMID:12818410 |
RGD:2311677 |
NCBI chr16:74,098,263...74,122,897
Ensembl chr16:74,098,260...74,122,889
|
|
G |
Plaur |
plasminogen activator, urokinase receptor |
|
ISO |
|
RGD |
PMID:21372607 |
RGD:6484121 |
NCBI chr 1:81,328,171...81,344,954
Ensembl chr 1:81,328,183...81,344,708
|
|
G |
Plin1 |
perilipin 1 |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism DNA:snp:intron:g.11482G>A (human) |
CTD |
PMID:15001633, PMID:11371650, PMID:15985482 |
RGD:737723, RGD:1581041 |
NCBI chr 1:141,458,907...141,470,927
Ensembl chr 1:141,458,181...141,471,010
|
|
G |
Plscr3 |
phospholipid scramblase 3 |
|
ISS |
OMIM:601665 |
MouseDO |
|
|
NCBI chr10:56,452,632...56,458,390
Ensembl chr10:56,453,877...56,458,390
|
|
G |
Pmch |
pro-melanin-concentrating hormone |
|
IEP ISO |
associated with Hyperphagia;protein:increased expression:hypothalamus CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12355323, PMID:15363890, PMID:12453827 |
RGD:1624360, RGD:1642486 |
NCBI chr 7:28,655,206...28,656,522
Ensembl chr 7:28,654,733...28,657,522
|
|
G |
Pnlip |
pancreatic lipase |
susceptibility |
IAGP |
|
RGD |
PMID:15883013 |
RGD:1358859 |
NCBI chr 1:279,798,187...279,811,372
Ensembl chr 1:279,798,187...279,811,372
|
|
G |
Pnpla3 |
patatin-like phospholipase domain containing 3 |
|
IEP |
|
RGD |
PMID:11431482 |
RGD:14985224 |
NCBI chr 7:125,034,760...125,056,165
Ensembl chr 7:125,034,764...125,055,976
|
|
G |
Pogz |
pogo transposable element derived with ZNF domain |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
|
|
NCBI chr 2:195,995,322...196,041,500
Ensembl chr 2:195,996,521...196,041,497
|
|
G |
Pomc |
proopiomelanocortin |
|
ISO |
DNA:mutations:multiple (human) ClinVar Annotator: match by term: Obesity ClinVar Annotator: match by term: Obesity, early-onset, susceptibility to ClinVar Annotator: match by term: Monogenic Non-Syndromic Obesity CTD Direct Evidence: marker/mechanism |
ClinVar CTD OMIM |
PMID:8302318 PMID:9768693 PMID:10193875 PMID:11941477 PMID:12165561 PMID:16289378 PMID:16459314 PMID:18091355 PMID:18697863 PMID:19153526 PMID:19221669 PMID:20349035 PMID:23293326 PMID:25741868 PMID:28492532, PMID:15189116 |
RGD:1357925 |
NCBI chr 6:28,382,937...28,388,771
Ensembl chr 6:28,382,962...28,388,967
|
|
G |
Pon2 |
paraoxonase 2 |
|
IEP |
protein:increased expression:white adipose tissue |
RGD |
PMID:21365757 |
RGD:8661255 |
NCBI chr 4:30,344,705...30,380,119
Ensembl chr 4:30,344,709...30,380,119
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11089532 PMID:30738174 |
|
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:16168052 PMID:20176998 |
|
NCBI chr20:7,818,289...7,883,482
Ensembl chr20:7,818,289...7,885,333
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
susceptibility |
IEP ISO |
mRNA:increased expression:adipose tissue ClinVar Annotator: match by term: Obesity CTD Direct Evidence: marker/mechanism mRNA:decreased expression:retroperitoneal fat pad DNA:polymorphism DNA:point mutation:exon:P115Q |
ClinVar CTD OMIM |
PMID:9467001 PMID:9792554 PMID:10523018 PMID:10622252 PMID:10851250 PMID:11089532 PMID:14671186 PMID:15254591 PMID:22461176 PMID:25157153 PMID:25741868 PMID:28242765 PMID:28492532, PMID:18457007, PMID:15118671, PMID:18427128, PMID:18683148, PMID:9753710 |
RGD:2301884, RGD:1331525, RGD:2301859, RGD:2301847, RGD:1601443 |
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
treatment |
IDA IEP ISO |
mRNA:increased expression:retroperitoneal fat pad (rat) |
RGD |
PMID:23256146, PMID:22401878, PMID:23180161 |
RGD:7241848, RGD:7242183, RGD:7242011 |
NCBI chr14:63,095,291...63,190,688
Ensembl chr14:63,095,720...63,187,009
|
|
G |
Ppargc1b |
PPARG coactivator 1 beta |
resistance |
ISO |
DNA:polymorphism: :p.A203P ClinVar Annotator: match by term: Obesity, variation in CTD Direct Evidence: marker/mechanism |
ClinVar CTD |
PMID:15863669 PMID:30738174, PMID:15863669 |
RGD:1642501 |
NCBI chr18:56,626,725...56,650,524
Ensembl chr18:56,626,712...56,728,968
|
|
G |
Ppm1l |
protein phosphatase, Mg2+/Mn2+ dependent, 1L |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:18344982 |
|
NCBI chr 2:165,932,240...166,218,774
Ensembl chr 2:166,140,112...166,218,774
|
|
G |
Prg2 |
proteoglycan 2 |
|
ISO |
mRNA:decreased expression:placenta (human) |
RGD |
PMID:28125591 |
RGD:40902990 |
NCBI chr 3:72,385,678...72,389,245
Ensembl chr 3:72,385,666...72,389,276
|
|
G |
Prkar1a |
protein kinase cAMP-dependent type I regulatory subunit alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29367455 |
|
NCBI chr10:97,940,705...97,959,199
Ensembl chr10:97,940,705...97,957,336
|
|
G |
Prkar2b |
protein kinase cAMP-dependent type II regulatory subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20975297 |
|
NCBI chr 6:51,265,509...51,356,383
Ensembl chr 6:51,265,515...51,356,383
|
|
G |
Prkcb |
protein kinase C, beta |
|
IEP |
mRNA, protein:increased expression:mononuclear cell |
RGD |
PMID:17180352 |
RGD:1625512 |
NCBI chr 1:192,233,569...192,575,339
Ensembl chr 1:192,233,910...192,574,831
|
|
G |
Prkcd |
protein kinase C, delta |
|
IEP |
protein:decreased expression:heart ventricle |
RGD |
PMID:11478406 |
RGD:1642533 |
NCBI chr16:6,655,131...6,675,746
Ensembl chr16:6,655,120...6,675,746
|
|
G |
Prkch |
protein kinase C, eta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23563609 |
|
NCBI chr 6:96,479,243...96,677,368
Ensembl chr 6:96,479,430...96,676,225
|
|
G |
Prkci |
protein kinase C, iota |
|
ISS |
OMIM:601665 |
MouseDO |
|
|
NCBI chr 2:115,941,998...116,002,550
Ensembl chr 2:115,941,993...116,002,561
|
|
G |
Prkg1 |
protein kinase cGMP-dependent 1 |
|
IEP |
protein:increased expression:kidney, glomerulus |
RGD |
PMID:23454089 |
RGD:7777114 |
NCBI chr 1:248,982,039...250,300,952
|
|
G |
Prl |
prolactin |
|
ISO |
|
RGD |
PMID:8388614 |
RGD:1642559 |
NCBI chr17:39,814,236...39,824,299
Ensembl chr17:39,814,244...39,824,299
|
|
G |
Prlh |
prolactin releasing hormone |
|
IDA ISS |
OMIM:601665 |
MouseDO |
PMID:15854142 |
RGD:1641829 |
NCBI chr 9:98,111,391...98,114,831
Ensembl chr 9:98,113,346...98,114,248
|
|
G |
Prlhr |
prolactin releasing hormone receptor |
|
IAGP |
|
RGD |
PMID:15854142 |
RGD:1641829 |
NCBI chr 1:281,754,472...281,756,159
Ensembl chr 1:281,754,724...281,756,159
|
|
G |
Prox1 |
prospero homeobox 1 |
|
ISS |
OMIM:601665 |
MouseDO |
|
|
NCBI chr13:108,382,536...108,444,107
Ensembl chr13:108,382,399...108,443,294
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
ISO |
protein:increased expression:liver CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21156398, PMID:21978752 |
RGD:5508307 |
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
|
|
G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10744717 PMID:20075852 |
|
NCBI chr 3:164,665,462...164,711,936
Ensembl chr 3:164,665,532...164,711,848
|
|
G |
Ptprf |
protein tyrosine phosphatase, receptor type, F |
|
IEP ISO |
protein:increased expression:skeletal muscle:increased 42% in insulin-resistant obese (fa/fa) and 50% in diabetic (ZDF/Drt-fa/fa) Zucker rats (P<0.05) |
RGD |
PMID:7666792, PMID:7769120, PMID:9218523 |
RGD:1642732, RGD:1642727, RGD:1642733 |
NCBI chr 5:137,036,936...137,112,930
Ensembl chr 5:137,036,935...137,112,927
|
|
G |
Pyy |
peptide YY |
|
ISO |
ClinVar Annotator: match by OMIM:601665 CTD Direct Evidence: marker/mechanism |
ClinVar CTD |
PMID:10898754 PMID:11825645 PMID:16368708 |
|
NCBI chr10:90,047,989...90,049,155
Ensembl chr10:90,047,993...90,049,112
|
|
G |
Rab21 |
RAB21, member RAS oncogene family |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29273807 |
|
NCBI chr 7:58,261,985...58,286,770
Ensembl chr 7:58,261,992...58,286,770
|
|
G |
Rai1 |
retinoic acid induced 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15459175 PMID:19116176 |
|
NCBI chr10:46,511,271...46,571,591
Ensembl chr10:46,511,271...46,571,583
|
|
G |
Rapgef3 |
Rap guanine nucleotide exchange factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29273807 |
|
NCBI chr 7:139,232,263...139,254,668
Ensembl chr 7:139,232,251...139,254,551
|
|
G |
Rarres2 |
retinoic acid receptor responder 2 |
|
IEP |
protein:increased expression:serum: |
RGD |
PMID:31284705, PMID:30873215 |
RGD:15036824, RGD:15036825 |
NCBI chr 4:78,205,809...78,208,956
Ensembl chr 4:78,205,812...78,208,767
|
|
G |
Rb1 |
RB transcriptional corepressor 1 |
|
ISO |
mRNA:decreased expression:adipose tissue |
RGD |
PMID:23315497 |
RGD:8547988 |
NCBI chr15:55,081,582...55,209,060
Ensembl chr15:55,083,140...55,209,342
|
|
G |
Rbp4 |
retinol binding protein 4 |
|
IEP |
mRNA, protein:decreased expression:adipose tissue, serum |
RGD |
PMID:18401839 |
RGD:2302016 |
NCBI chr 1:256,806,476...256,813,678
Ensembl chr 1:256,806,472...256,813,711
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
|
ISO |
|
RGD |
PMID:18356846 |
RGD:2298856 |
NCBI chr 1:220,992,770...221,003,249
Ensembl chr 1:220,992,770...221,003,249
|
|
G |
Ren |
renin |
|
ISO |
mRNA:increased expression:abdomen, subcutaneous adipose tissue, mesenchymal stem cell (human) |
RGD |
PMID:22648117 |
RGD:6784503 |
NCBI chr13:50,502,724...50,513,953
Ensembl chr13:50,502,724...50,514,151
|
|
G |
Retn |
resistin |
|
ISO |
mRNA, protein:increased expression:subcutaneous adipose tissue, serum DNA:SNP:promoter:-420G>C (rs1862513) (human) |
RGD |
PMID:22816026, PMID:11201732, PMID:17598818 |
RGD:7207072, RGD:7207158, RGD:7207155 |
NCBI chr12:2,201,909...2,203,649
Ensembl chr12:2,201,891...2,204,249
|
|
G |
Rhoa |
ras homolog family member A |
|
IEP |
protein:increased expression:membrane, aorta, skeletal muscle |
RGD |
PMID:16267124 |
RGD:2298881 |
NCBI chr 8:117,082,440...117,116,244
Ensembl chr 8:117,106,576...117,116,167
|
|
G |
Rps6kb1 |
ribosomal protein S6 kinase B1 |
|
IEP |
protein:increased phosphorylation:skeletal muscle |
RGD |
PMID:15604215 |
RGD:1642978 |
NCBI chr10:73,824,200...73,865,503
Ensembl chr10:73,824,202...73,865,364
|
|
G |
Rsrc2 |
arginine and serine rich coiled-coil 2 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
|
|
NCBI chr12:38,274,290...38,294,294
Ensembl chr12:38,274,297...38,294,292
|
|
G |
Rxra |
retinoid X receptor alpha |
susceptibility |
ISO |
|
RGD |
PMID:15936932 |
RGD:1643104 |
NCBI chr 3:6,272,560...6,295,354
Ensembl chr 3:6,211,789...6,295,908
|
|
G |
Sat1 |
spermidine/spermine N1-acetyl transferase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr X:43,626,480...43,629,767
Ensembl chr X:43,625,169...43,629,765
|
|
G |
Scaper |
S-phase cyclin A-associated protein in the ER |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:25741868 PMID:30723319 |
|
NCBI chr 8:60,127,039...60,593,568
Ensembl chr 8:60,126,624...60,570,058
|
|
G |
Scd |
stearoyl-CoA desaturase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 1:264,159,966...264,173,061
Ensembl chr 1:264,160,129...264,172,729
|
|
G |
Sdc1 |
syndecan 1 |
|
ISO IEP |
mRNA:increased expression:liver |
RGD |
PMID:15189116, PMID:11522680 |
RGD:1357925, RGD:1643129 |
NCBI chr 6:33,885,576...33,908,038
Ensembl chr 6:33,885,495...33,908,016
|
|
G |
Sdc3 |
syndecan 3 |
|
ISO |
ClinVar Annotator: match by term: Obesity, association with |
OMIM ClinVar |
PMID:17018662 |
|
NCBI chr 5:148,923,098...148,956,404
Ensembl chr 5:148,923,098...148,956,404
|
|
G |
Selp |
selectin P |
|
ISO |
associated with Diabetes Mellitus, Non-Insulin-Dependent;protein:altered localization:platelet |
RGD |
PMID:19228864 |
RGD:2312291 |
NCBI chr13:82,428,914...82,464,629
Ensembl chr13:82,429,063...82,464,628
|
|
G |
Serpina12 |
serpin family A member 12 |
treatment |
IDA |
|
RGD |
PMID:16030142 |
RGD:1547845 |
NCBI chr 6:127,696,501...127,711,238
Ensembl chr 6:127,696,252...127,711,212
|
|
G |
Serpine1 |
serpin family E member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23819014 |
|
NCBI chr12:22,641,104...22,651,482
Ensembl chr12:22,641,104...22,651,482
|
|
G |
Serpinf1 |
serpin family F member 1 |
|
ISO IEP |
protein:increased expression:serum (rat) |
RGD |
PMID:17491674, PMID:24424059 |
RGD:2312347, RGD:8633067 |
NCBI chr10:62,241,750...62,254,145
Ensembl chr10:62,241,756...62,254,287
|
|
G |
Sftpa1 |
surfactant protein A1 |
|
IEP |
protein:increased expression:lung |
RGD |
PMID:15136884 |
RGD:4143472 |
NCBI chr16:18,716,019...18,719,404
Ensembl chr16:18,716,019...18,719,403
|
|
G |
Sftpb |
surfactant protein B |
|
IEP |
protein:increased expression:lung |
RGD |
PMID:15136884 |
RGD:4143472 |
NCBI chr 4:100,166,855...100,175,941
Ensembl chr 4:100,166,863...100,175,938
|
|
G |
Sh2b1 |
SH2B adaptor protein 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19079261 |
|
NCBI chr 1:197,878,839...197,888,223
Ensembl chr 1:197,878,840...197,886,759
|
|
G |
Sim1 |
SIM bHLH transcription factor 1 |
|
ISO ISS |
DNA:translocation ClinVar Annotator: match by term: Obesity due to SIM1 deficiency OMIM:601665 |
ClinVar MouseDO |
PMID:2152513 PMID:16924270 PMID:19401419 PMID:21512513 PMID:23778136 PMID:23778139 PMID:24097297 PMID:25234154 PMID:25741868 PMID:26795956 PMID:28492532, PMID:10587584 |
RGD:1624165 |
NCBI chr20:55,590,810...55,674,002
Ensembl chr20:55,594,676...55,673,995
|
|
G |
Sirt1 |
sirtuin 1 |
treatment |
IMP ISO IEP |
CTD Direct Evidence: therapeutic protein:decreased expression:ovary |
CTD |
PMID:24184811, PMID:24773342, PMID:24135502 |
RGD:9585762, RGD:9586064 |
NCBI chr20:26,831,971...26,851,587
Ensembl chr20:26,833,357...26,852,199
|
|
G |
Sirt3 |
sirtuin 3 |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:23956348, PMID:21901160 |
RGD:9586047 |
NCBI chr 1:213,613,502...213,636,061
Ensembl chr 1:213,613,513...213,635,546
|
|
G |
Sirt6 |
sirtuin 6 |
|
IEP |
protein:decreased expression:ovary |
RGD |
PMID:24135502 |
RGD:9586064 |
NCBI chr 7:10,937,622...10,943,048
Ensembl chr 7:10,937,599...10,943,063
|
|
G |
Slc10a1 |
solute carrier family 10 member 1 |
disease_progression |
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:25612518 |
RGD:15045599 |
NCBI chr 6:104,617,730...104,631,355
Ensembl chr 6:104,617,730...104,631,355
|
|
G |
Slc16a7 |
solute carrier family 16 member 7 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 7:68,438,341...68,606,312
Ensembl chr 7:68,446,193...68,549,763
|
|
G |
Slc22a1 |
solute carrier family 22 member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20956498 |
|
NCBI chr 1:48,273,639...48,300,645
Ensembl chr 1:48,273,611...48,300,655
|
|
G |
Slc22a2 |
solute carrier family 22 member 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27401566 |
|
NCBI chr 1:48,318,025...48,360,219
Ensembl chr 1:48,317,995...48,360,261
|
|
G |
Slc22a3 |
solute carrier family 22 member 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:27401566 |
|
NCBI chr 1:48,433,079...48,521,261
Ensembl chr 1:48,433,079...48,521,256
|
|
G |
Slc27a1 |
solute carrier family 27 member 1 |
susceptibility |
ISO IEP |
protein:increased expression:soleus muscle, protein:decreased expression:gastrocnemius muscle |
RGD |
PMID:16611988, PMID:15281014 |
RGD:1642790, RGD:1642794 |
NCBI chr16:19,997,823...20,016,193
Ensembl chr16:19,999,112...20,016,190
|
|
G |
Slc27a4 |
solute carrier family 27 member 4 |
|
ISO |
mRNA:increased expression:subcutaneous adipose tissue |
RGD |
PMID:15168018 |
RGD:1625638 |
NCBI chr 3:8,363,937...8,376,858
Ensembl chr 3:8,363,937...8,376,858
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
treatment |
ISO |
associated with Polycystic Ovary Syndrome |
RGD |
PMID:24842895 |
RGD:12879503 |
NCBI chr 5:138,154,677...138,182,897
Ensembl chr 5:138,154,673...138,182,897
|
|
G |
Slc6a1 |
solute carrier family 6 member 1 |
|
ISO |
|
RGD |
PMID:11191352 |
RGD:1643191 |
NCBI chr 4:146,258,842...146,292,176
Ensembl chr 4:146,276,862...146,292,213
|
|
G |
Slc6a14 |
solute carrier family 6 member 14 |
susceptibility |
ISO |
DNA:SNPs |
RGD |
PMID:15331564 |
RGD:1625271 |
NCBI chr X:120,624,522...120,647,964
Ensembl chr X:120,624,518...120,649,111
|
|
G |
Slc6a3 |
solute carrier family 6 member 3 |
no_association susceptibility |
ISO |
DNA:polymorphism |
RGD |
PMID:16674552, PMID:12490667 |
RGD:1625653, RGD:1625655 |
NCBI chr 1:32,323,011...32,363,983
Ensembl chr 1:32,321,580...32,363,983
|
|
G |
Slc9a3 |
solute carrier family 9 member A3 |
|
IEP |
protein:decreased expression:kidney cortex |
RGD |
PMID:16757903 |
RGD:1625672 |
NCBI chr 1:31,731,652...31,777,144
Ensembl chr 1:31,734,327...31,777,070
|
|
G |
Smarca4 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:28492532 |
|
NCBI chr 8:22,648,323...22,739,468
Ensembl chr 8:22,648,323...22,739,468
|
|
G |
Snap25 |
synaptosome associated protein 25 |
|
ISS |
OMIM:601665 |
MouseDO |
|
|
NCBI chr 3:129,697,408...129,788,417
Ensembl chr 3:129,599,353...129,788,400
|
|
G |
Socs1 |
suppressor of cytokine signaling 1 |
|
IEP |
mRNA, protein:increased expression:white fat |
RGD |
PMID:11027633 |
RGD:2298920 |
NCBI chr10:4,956,795...4,958,472
Ensembl chr10:4,957,326...4,958,461
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
|
IEP ISO |
mRNA, protein:increased expression:white fat mRNA:decreased expression:subcutaneous adipose tissue mRNA:altered expression:skeletal muscle, subcutaneous adipose tissue |
RGD |
PMID:11027633, PMID:16920065, PMID:15331532 |
RGD:2298920, RGD:1625676, RGD:2313790 |
NCBI chr10:106,973,863...106,976,969
Ensembl chr10:106,975,178...106,976,040
|
|
G |
Sod1 |
superoxide dismutase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:24042701 |
|
NCBI chr11:30,363,282...30,368,858
Ensembl chr11:30,363,280...30,368,862
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16317704 PMID:23956348 PMID:30738174 |
|
NCBI chr 1:47,914,757...47,921,587
Ensembl chr 1:47,914,759...47,921,587
|
|
G |
Sorbs1 |
sorbin and SH3 domain containing 1 |
|
ISO |
DNA:SNP: :p.T228A (human) |
RGD |
PMID:11532984 |
RGD:1642744 |
NCBI chr 1:259,373,921...259,502,108
Ensembl chr 1:259,376,933...259,484,569
|
|
G |
Sparc |
secreted protein acidic and cysteine rich |
|
ISO |
mRNA:increased expression:adipose tissue |
RGD |
PMID:11294850 |
RGD:2300062 |
NCBI chr10:40,742,390...40,764,232
Ensembl chr10:40,742,400...40,764,185
|
|
G |
Sqle |
squalene epoxidase |
|
ISO |
|
RGD |
PMID:15556298 |
RGD:1581399 |
NCBI chr 7:99,609,929...99,624,803
Ensembl chr 7:99,609,191...99,624,732
|
|
G |
Srd5a1 |
steroid 5 alpha-reductase 1 |
|
IEP |
mRNA:increased expression:liver (rat) |
RGD |
PMID:20098742 |
RGD:4891511 |
NCBI chr 1:36,320,504...36,354,694
Ensembl chr 1:36,320,461...36,354,756
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:10900012 |
|
NCBI chr10:46,570,996...46,593,021
Ensembl chr10:46,570,996...46,593,009
|
|
G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
|
IEP |
protein:increased expression:fat cell, nucleus |
RGD |
PMID:9786926 |
RGD:2308843 |
NCBI chr 7:123,381,082...123,438,605
Ensembl chr 7:123,381,077...123,438,603
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
IDA |
protein:decreased phosphorylation:hypothalamus |
RGD |
PMID:23397595 |
RGD:10411893 |
NCBI chr10:88,790,401...88,842,263
Ensembl chr10:88,790,408...88,842,233
|
|
G |
Stat4 |
signal transducer and activator of transcription 4 |
treatment |
IDA |
|
RGD |
PMID:20978234 |
RGD:5509594 |
NCBI chr 9:54,340,649...54,457,753
Ensembl chr 9:54,287,541...54,484,533
|
|
G |
Stk11 |
serine/threonine kinase 11 |
|
IEP |
protein:decreased expression:gastrocnemius |
RGD |
PMID:16352671 |
RGD:1601389 |
NCBI chr 7:12,440,751...12,457,513
Ensembl chr 7:12,440,751...12,457,513
|
|
G |
Sts |
steroid sulfatase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:24497646 |
|
NCBI chr X:45,420,418...45,428,748
Ensembl chr X:45,420,596...45,428,750
|
|
G |
Sucla2 |
succinate-CoA ligase ADP-forming subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr15:55,461,695...55,516,954
Ensembl chr15:55,461,695...55,516,952
|
|
G |
Suclg2 |
succinate-CoA ligase GDP-forming subunit beta |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 4:127,552,100...127,824,970
Ensembl chr 4:127,552,101...127,824,970
|
|
G |
Szt2 |
SZT2 subunit of KICSTOR complex |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:25741868 |
|
NCBI chr 5:137,192,120...137,238,384
Ensembl chr 5:137,190,875...137,238,354
|
|
G |
Tbc1d1 |
TBC1 domain family member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:16893906 PMID:18325908 PMID:18931681 |
|
NCBI chr14:45,598,753...45,797,650
Ensembl chr14:45,598,743...45,797,887
|
|
G |
Tbx3 |
T-box transcription factor 3 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:28492532 |
|
NCBI chr12:42,479,518...42,494,588
Ensembl chr12:42,480,560...42,492,526
|
|
G |
Tbxa2r |
thromboxane A2 receptor |
|
ISO |
mRNA:increased expression:carotid artery |
RGD |
PMID:12409963 |
RGD:1601447 |
NCBI chr 7:11,253,153...11,259,233
Ensembl chr 7:11,253,180...11,257,977
|
|
G |
Tf |
transferrin |
|
IEP ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379, PMID:16267817 |
RGD:1601520 |
NCBI chr 8:111,694,570...111,721,275
Ensembl chr 8:111,673,547...111,721,333
|
|
G |
Tfam |
transcription factor A, mitochondrial |
|
ISO |
|
RGD |
PMID:21862610 |
RGD:5683906 |
NCBI chr20:18,594,057...18,606,106
Ensembl chr20:18,594,037...18,606,151
|
|
G |
Tfrc |
transferrin receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17062801 PMID:20882379 |
|
NCBI chr11:71,397,423...71,419,263
Ensembl chr11:71,397,383...71,419,223
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
severity |
ISO IEP |
associated with hypertension;protein:increased expression:blood protein:increased expression:adipose tissue protein:increased expression:platelet |
RGD |
PMID:15944724, PMID:16253647, PMID:16477387 |
RGD:1601579, RGD:1601563, RGD:1601561 |
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
|
|
G |
Th |
tyrosine hydroxylase |
resistance |
ISO |
DNA:polymorphism:intron:g.1170_1173dupTCAT (human) |
RGD |
PMID:16251897 |
RGD:1601632 |
NCBI chr 1:216,073,034...216,080,287
Ensembl chr 1:216,073,031...216,080,287
|
|
G |
Thbd |
thrombomodulin |
severity |
ISO |
protein:increased expression:plasma |
RGD |
PMID:16651309 |
RGD:1601640 |
NCBI chr 3:142,748,673...142,752,325
Ensembl chr 3:142,748,674...142,752,325
|
|
G |
Thbs1 |
thrombospondin 1 |
|
ISO |
mRNA,protein:increased expression:mononuclear cell, adipose tissue: |
RGD |
PMID:24086512 |
RGD:9681453 |
NCBI chr 3:109,862,120...109,873,466
Ensembl chr 3:109,862,117...109,873,466
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:17512313 |
RGD:1642026 |
NCBI chr X:1,364,771...1,369,451
Ensembl chr X:1,364,786...1,369,384
|
|
G |
Tlr2 |
toll-like receptor 2 |
|
ISO |
|
RGD |
PMID:18787058 |
RGD:2312681 |
NCBI chr 2:182,840,171...182,846,061
Ensembl chr 2:182,840,727...182,846,061
|
|
G |
Tlr4 |
toll-like receptor 4 |
susceptibility |
ISO IMP |
|
RGD |
PMID:19144836, PMID:19144836, PMID:17053832 |
RGD:2312510, RGD:2312510, RGD:1620653 |
NCBI chr 5:82,587,424...82,601,056
Ensembl chr 5:82,587,420...82,601,052
|
|
G |
Tmem18 |
transmembrane protein 18 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19079261 |
|
NCBI chr 6:49,529,228...49,534,960
Ensembl chr 6:49,529,228...49,536,648
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:9502777 PMID:11328671 PMID:20141834 PMID:29035695, PMID:24146106, PMID:28843383 |
RGD:10450599, RGD:14975146 |
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:12935365 |
RGD:1624179 |
NCBI chr 4:157,864,905...157,877,634
Ensembl chr 4:157,864,969...157,877,633
|
|
G |
Tnfrsf1b |
TNF receptor superfamily member 1B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11782876 |
|
NCBI chr 5:163,136,390...163,167,299
Ensembl chr 5:163,136,390...163,167,299
|
|
G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17347480 |
|
NCBI chr10:59,799,123...59,824,208
Ensembl chr10:59,799,123...59,824,679
|
|
G |
Tsc1 |
TSC complex subunit 1 |
|
IDA |
DNA:hypermethylation:promoter |
RGD |
PMID:25807795 |
RGD:11570513 |
NCBI chr 3:7,219,955...7,269,063
Ensembl chr 3:7,237,192...7,265,145
|
|
G |
Tub |
TUB bipartite transcription factor |
no_association susceptibility |
ISO ISS |
OMIM:601665 DNA:splice-site mutation |
MouseDO |
PMID:8772727, PMID:8612280 |
RGD:1625564, RGD:1625565 |
NCBI chr 1:173,550,929...173,629,550
Ensembl chr 1:173,607,101...173,625,550
|
|
G |
Tyk2 |
tyrosine kinase 2 |
|
ISS |
OMIM:601665 |
MouseDO |
|
|
NCBI chr 8:22,118,224...22,149,807
Ensembl chr 8:22,124,560...22,150,005
|
|
G |
Ucn |
urocortin |
treatment |
ISO |
|
RGD |
PMID:17932219 |
RGD:1642774 |
NCBI chr 6:26,602,144...26,602,974
Ensembl chr 6:26,602,144...26,602,974
|
|
G |
Ucp1 |
uncoupling protein 1 |
no_association |
ISO |
DNA:polymorphism: :-3826A>G (human) CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:15592485, PMID:8968850 |
RGD:1624977 |
NCBI chr19:24,456,976...24,464,808
Ensembl chr19:24,456,976...24,464,807
|
|
G |
Ucp2 |
uncoupling protein 2 |
susceptibility |
ISO |
DNA:polymorphism, insertion:promoter:-866G>A (rs659366)(human) CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Body mass index quantitative trait locus 4 DNA:SNPs, insertion/deletion, haplotypes:promoter, 3' utr:-2723T>A, -866G>A, *158_159ins45 (human) |
CTD OMIM ClinVar |
PMID:11381268 PMID:15562023 PMID:25741868, PMID:17870627, PMID:11381268 |
RGD:2313512, RGD:737761 |
NCBI chr 1:165,506,375...165,512,744
Ensembl chr 1:165,506,361...165,512,744
|
|
G |
Ucp3 |
uncoupling protein 3 |
susceptibility no_association |
ISO |
DNA:SNP:exon:p.V102I (human) ClinVar Annotator: match by term: Obesity, severe, and type II diabetes DNA:polymorphism:promoter:-55C>T (human) DNA:polymorphism:exon (human) |
ClinVar OMIM |
PMID:9769326 PMID:28492532, PMID:9769326, PMID:14673524, PMID:18249216, PMID:9700198, PMID:15118671, PMID:12145158 |
RGD:1625189, RGD:2313518, RGD:2313506, RGD:2313526, RGD:1331525, RGD:2313519 |
NCBI chr 1:165,482,912...165,495,895
Ensembl chr 1:165,482,155...165,496,206
|
|
G |
Ulk4 |
unc-51 like kinase 4 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
|
|
NCBI chr 8:129,631,003...129,919,080
Ensembl chr 8:129,632,149...129,919,120
|
|
G |
Uqcrc2 |
ubiquinol cytochrome c reductase core protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20882379 |
|
NCBI chr 1:190,555,177...190,585,741
Ensembl chr 1:190,555,177...190,585,734
|
|
G |
Vcam1 |
vascular cell adhesion molecule 1 |
|
ISO |
associated with Diabetes Mellitus, Non-Insulin-Dependent |
RGD |
PMID:19260948 |
RGD:2312763 |
NCBI chr 2:219,071,193...219,090,931
Ensembl chr 2:219,071,193...219,097,619
|
|
G |
Vdr |
vitamin D receptor |
|
ISO |
|
GAD |
PMID:15118671 |
RGD:1331525 |
NCBI chr 7:139,344,452...139,394,138
Ensembl chr 7:139,342,063...139,394,166
|
|
G |
Vgf |
VGF nerve growth factor inducible |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:12177191 |
|
NCBI chr12:22,677,302...22,680,630
Ensembl chr12:22,677,607...22,680,630
|
|
G |
Vldlr |
very low density lipoprotein receptor |
susceptibility |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:20975297, PMID:11557677 |
RGD:1625568 |
NCBI chr 1:245,236,819...245,273,688
Ensembl chr 1:245,237,736...245,269,205
|
|
G |
Vwf |
von Willebrand factor |
|
ISO |
protein:increased expression:plasma associated with Diabetes Mellitus, Type 2;protein:increased expression:plasma |
RGD |
PMID:16631442, PMID:16739871 |
RGD:1625711, RGD:1625710 |
NCBI chr 4:158,085,059...158,219,525
Ensembl chr 4:158,088,505...158,219,523
|
|
G |
Wnt10b |
Wnt family member 10B |
|
ISO |
|
RGD |
PMID:17578883, PMID:16477437 |
RGD:2326237, RGD:2300029 |
NCBI chr 7:140,448,284...140,466,159
Ensembl chr 7:140,448,465...140,454,268
|
|
G |
Wnt3a |
Wnt family member 3A |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:28242765 |
|
NCBI chr10:45,598,898...45,643,151
Ensembl chr10:45,598,912...45,638,035
|
|
G |
Xdh |
xanthine dehydrogenase |
treatment |
IEP |
|
RGD |
PMID:7616299 |
RGD:13210504 |
NCBI chr 6:25,149,570...25,211,273
Ensembl chr 6:25,149,235...25,211,494
|
|
G |
Zbtb7b |
zinc finger and BTB domain containing 7B |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29273807 |
|
NCBI chr 2:188,704,989...188,719,674
Ensembl chr 2:188,704,687...188,718,704
|
|
G |
Zfhx3 |
zinc finger homeobox 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29273807 |
|
NCBI chr19:42,753,983...42,925,794
Ensembl chr19:42,758,127...42,920,344
|
|
G |
Zfp169 |
zinc finger protein 169 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29273807 |
|
NCBI chr17:16,443,324...16,471,329
Ensembl chr17:16,455,026...16,470,842
|
|
G |
Zfp26 |
zinc finger protein 26 |
|
ISO |
ClinVar Annotator: match by term: Obesity |
ClinVar |
PMID:25741868 |
|
NCBI chr 8:21,444,833...21,466,474
Ensembl chr 8:21,448,618...21,458,379
|
|
G |
Zfr2 |
zinc finger RNA binding protein 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29273807 |
|
NCBI chr 7:11,335,024...11,353,743
Ensembl chr 7:11,335,478...11,353,713
|
|
|
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15199296 |
|
NCBI chr13:111,946,626...111,996,536
Ensembl chr13:111,926,442...111,972,603
|
|
|
G |
Ctf1 |
cardiotrophin 1 |
|
ISS |
|
MouseDO |
|
|
NCBI chr 1:199,162,319...199,168,296
Ensembl chr 1:199,163,086...199,168,296
|
|
G |
Gucy2c |
guanylate cyclase 2C |
|
ISS |
|
MouseDO |
|
|
NCBI chr 4:170,659,993...170,740,274
Ensembl chr 4:170,659,998...170,740,274
|
|
G |
Lep |
leptin |
|
ISS |
|
MouseDO |
|
|
NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
|
|
G |
Neil1 |
nei-like DNA glycosylase 1 |
|
ISS |
|
MouseDO |
|
|
NCBI chr 8:61,817,258...61,824,023
Ensembl chr 8:61,817,258...61,823,102
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:15309680 |
|
NCBI chr 7:126,618,872...126,687,282
Ensembl chr 7:126,619,196...126,681,752
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
ISS |
|
MouseDO |
|
|
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
|
|
G |
Ppargc1a |
PPARG coactivator 1 alpha |
|
IEP |
mRNA:increased expression:gastrocnemius muscle (rat) |
RGD |
PMID:23320128 |
RGD:7241841 |
NCBI chr14:63,095,291...63,190,688
Ensembl chr14:63,095,720...63,187,009
|
|
G |
Prkci |
protein kinase C, iota |
|
ISS |
|
MouseDO |
|
|
NCBI chr 2:115,941,998...116,002,550
Ensembl chr 2:115,941,993...116,002,561
|
|
G |
Sirt3 |
sirtuin 3 |
|
ISS |
|
MouseDO |
|
|
NCBI chr 1:213,613,502...213,636,061
Ensembl chr 1:213,613,513...213,635,546
|
|
|
G |
Atp2a2 |
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2 |
|
IDA |
protein:increased oxidation:cardiac muscle cell |
RGD |
PMID:23997093 |
RGD:13782087 |
NCBI chr12:39,553,903...39,603,326
Ensembl chr12:39,553,903...39,603,326
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:27131981 |
RGD:13792503 |
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
treatment |
IEP |
|
RGD |
PMID:27131981 |
RGD:13792503 |
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
|
|
G |
Fadd |
Fas associated via death domain |
treatment |
IEP |
|
RGD |
PMID:27131981 |
RGD:13792503 |
NCBI chr 1:217,746,176...217,748,581
Ensembl chr 1:217,742,929...217,748,628
|
|
G |
Fas |
Fas cell surface death receptor |
|
IEP |
|
RGD |
PMID:30172001 |
RGD:13792561 |
NCBI chr 1:252,589,785...252,624,790
Ensembl chr 1:252,589,785...252,624,790
|
|
G |
Lep |
leptin |
|
ISS |
OMIM:605552 |
MouseDO |
|
|
NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
|
|
G |
Lpl |
lipoprotein lipase |
treatment |
IDA |
|
RGD |
PMID:26996629 |
RGD:13794382 |
NCBI chr16:22,537,687...22,561,487
Ensembl chr16:22,537,056...22,561,496
|
|
G |
Mttp |
microsomal triglyceride transfer protein |
|
ISO |
ClinVar Annotator: match by term: Metabolic syndrome, protection against |
ClinVar OMIM |
PMID:16721486 |
|
NCBI chr 2:243,366,181...243,407,608
Ensembl chr 2:243,366,181...243,407,608
|
|
G |
Tlr2 |
toll-like receptor 2 |
susceptibility |
ISO |
|
RGD |
PMID:19841034 |
RGD:15090861 |
NCBI chr 2:182,840,171...182,846,061
Ensembl chr 2:182,840,727...182,846,061
|
|
G |
Tp53inp1 |
tumor protein p53 inducible nuclear protein 1 |
|
ISS |
OMIM:605552 |
MouseDO |
|
|
NCBI chr 5:24,402,895...24,419,651
Ensembl chr 5:24,410,863...24,416,888
|
|
|
G |
Ahdc1 |
AT hook, DNA binding motif, containing 1 |
|
ISO |
ClinVar Annotator: match by term: Abdominal obesity-metabolic syndrome 3 |
ClinVar |
PMID:25741868 |
|
NCBI chr 5:151,209,894...151,277,192
Ensembl chr 5:151,211,342...151,277,165
|
|
G |
Dyrk1b |
dual specificity tyrosine phosphorylation regulated kinase 1B |
|
ISO |
ClinVar Annotator: match by OMIM:615812 |
OMIM ClinVar |
PMID:24827035 |
|
NCBI chr 1:85,112,819...85,120,840
Ensembl chr 1:85,112,247...85,120,839
|
|
|
G |
Cela2a |
chymotrypsin like elastase 2A |
|
ISO |
ClinVar Annotator: match by term: Abdominal obesity-metabolic syndrome 4 |
OMIM ClinVar |
PMID:31358993 |
|
NCBI chr 5:160,374,031...160,383,782
Ensembl chr 5:160,374,031...160,383,782
|
|
G |
Lipe |
lipase E, hormone sensitive type |
|
ISO |
ClinVar Annotator: match by term: Abdominal obesity-metabolic syndrome 4 |
ClinVar |
PMID:25741868 |
|
NCBI chr 1:82,248,031...82,266,727
Ensembl chr 1:82,248,046...82,266,727
|
|
|
G |
Phf6 |
PHD finger protein 6 |
|
ISO |
ClinVar Annotator: match by term: Borjeson-Forssman-Lehmann syndrome ClinVar Annotator: match by OMIM:301900 ClinVar Annotator: match by null |
OMIM ClinVar |
PMID:12415272 PMID:13871358 PMID:15241480 PMID:15466013 PMID:15994862 PMID:18414213 PMID:23906836 PMID:24728327 PMID:25741868 PMID:25741869 PMID:27633282 PMID:28492532 |
|
NCBI chr X:158,698,353...158,739,855
Ensembl chr X:158,698,356...158,739,838 Ensembl chr X:158,698,356...158,739,838
|
|
|
G |
Aff4 |
AF4/FMR2 family, member 4 |
|
ISO |
ClinVar Annotator: match by term: Chops syndrome |
ClinVar OMIM |
PMID:25730767 PMID:25741868 PMID:28492532 |
|
NCBI chr10:38,692,167...38,773,021
Ensembl chr10:38,692,211...38,773,021
|
|
|
G |
Trio |
trio Rho guanine nucleotide exchange factor |
|
ISO |
ClinVar Annotator: match by term: Clark-Baraitser syndrome |
ClinVar |
PMID:25741868 |
|
NCBI chr 2:80,471,398...80,769,313
Ensembl chr 2:80,473,202...80,667,481
|
|
G |
Trip12 |
thyroid hormone receptor interactor 12 |
|
ISO |
ClinVar Annotator: match by term: MENTAL RETARDATION, AUTOSOMAL DOMINANT 49 ClinVar Annotator: match by term: Clark-Baraitser syndrome |
ClinVar OMIM |
PMID:3812552 PMID:25363768 PMID:25741868 PMID:27848077 PMID:28251352 PMID:28660352 PMID:31814248 |
|
NCBI chr 9:92,305,059...92,435,388
Ensembl chr 9:92,305,051...92,435,365
|
|
|
G |
Mir875 |
microRNA 875 |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome |
ClinVar |
PMID:15141358 PMID:16648375 PMID:28492532 |
|
NCBI chr 7:74,423,233...74,423,305
Ensembl chr 7:74,423,233...74,423,305
|
|
G |
Vps13b |
vacuolar protein sorting 13 homolog B |
|
ISO |
ClinVar Annotator: match by term: Cohen syndrome ClinVar Annotator: match by term: Pepper syndrome ClinVar Annotator: match by OMIM:216550 CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:11169562 PMID:12730828 PMID:15141358 PMID:15154116 PMID:15173253 PMID:15211651 PMID:15498460 PMID:15691367 PMID:16648375 PMID:16917849 PMID:17383910 PMID:17786118 PMID:17990063 PMID:18414213 PMID:18655112 PMID:19006247 PMID:19190672 PMID:19533689 PMID:20461111 PMID:20656880 PMID:20683995 PMID:20921020 PMID:21330571 PMID:21659346 PMID:21865173 PMID:22382802 PMID:22527104 PMID:22855652 PMID:23033978 PMID:23188044 PMID:23352163 PMID:23757202 PMID:24033266 PMID:24311531 PMID:24334764 PMID:25326635 PMID:25356970 PMID:25472526 PMID:25502226 PMID:25525159 PMID:25533962 PMID:25741868 PMID:26133662 PMID:26395554 PMID:26443248 PMID:26467025 PMID:26938784 PMID:27175599 PMID:27353947 PMID:27380831 PMID:27533158 PMID:27829003 PMID:28041643 PMID:28341476 PMID:28492532 PMID:28631888 PMID:28832562 PMID:29431110 PMID:29453417 PMID:29706646 PMID:29758347 PMID:30138938 PMID:30602132 PMID:32860008 |
|
NCBI chr 7:74,118,834...74,722,341
|
|
|
G |
Lep |
leptin |
|
ISO |
ClinVar Annotator: match by term: Leptin deficiency or dysfunction ClinVar Annotator: match by term: Leptin dysfunction ClinVar Annotator: match by OMIM:614962 |
OMIM ClinVar |
PMID:9202122 PMID:9500540 PMID:9745435 PMID:12393845 PMID:15070752 PMID:15472169 PMID:15937081 PMID:20140086 PMID:25551525 PMID:25741868 PMID:28209183 PMID:28492532 |
|
NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
|
|
|
G |
Irak1bp1 |
interleukin-1 receptor-associated kinase 1 binding protein 1 |
|
ISO |
ClinVar Annotator: match by term: DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES ClinVar Annotator: match by term: Developmental delay, intellectual disability, obesity, and dysmorphic features |
ClinVar |
PMID:23033978 PMID:25741868 PMID:29209020 |
|
NCBI chr 8:90,343,307...90,360,085
Ensembl chr 8:90,343,154...90,360,086
|
|
G |
Phip |
pleckstrin homology domain interacting protein |
|
ISO |
ClinVar Annotator: match by term: DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES ClinVar Annotator: match by term: Developmental delay, intellectual disability, obesity, and dysmorphic features |
ClinVar OMIM |
PMID:23033978 PMID:25741868 PMID:27479843 PMID:27900362 PMID:28263302 PMID:29209020 |
|
NCBI chr 8:90,387,339...90,483,964
Ensembl chr 8:90,392,143...90,483,077
|
|
|
G |
Lepr |
leptin receptor |
|
ISO |
ClinVar Annotator: match by term: Leptin receptor deficiency ClinVar Annotator: match by term: LEPR-Related Disorders ClinVar Annotator: match by term: OBESITY, MORBID, NONSYNDROMIC 2 ClinVar Annotator: match by OMIM:614963 ClinVar Annotator: match by This custom term has been created by RGD curators. |
OMIM ClinVar |
PMID:8666155 PMID:9144432 PMID:9537324 PMID:9860295 PMID:11354636 PMID:11380591 PMID:11443193 PMID:12006639 PMID:12646666 PMID:15585384 PMID:16284652 PMID:17229951 PMID:17785359 PMID:18212354 PMID:18490929 PMID:18703626 PMID:21393862 PMID:21744741 PMID:22331430 PMID:22810975 PMID:24611737 PMID:25741868 PMID:26094658 PMID:26467025 PMID:28492532 PMID:29970488 |
|
NCBI chr 5:120,503,475...120,682,281
Ensembl chr 5:120,564,645...120,682,221
|
|
G |
Leprot |
leptin receptor overlapping transcript |
|
ISO |
ClinVar Annotator: match by term: OBESITY, MORBID, NONSYNDROMIC 2 ClinVar Annotator: match by term: Leptin receptor deficiency |
ClinVar |
PMID:28492532 |
|
NCBI chr 5:120,498,910...120,511,011
Ensembl chr 5:120,498,883...120,511,017
|
|
|
G |
Eif2s3 |
eukaryotic translation initiation factor 2 subunit gamma |
|
ISO |
ClinVar Annotator: match by term: Mental retardation, epileptic seizures, hypogonadism and hypogenitalism, microcephaly, and obesity ClinVar Annotator: match by term: MEHMO syndrome |
ClinVar OMIM |
PMID:23063529 PMID:25741868 PMID:25741869 PMID:27333055 PMID:28055140 |
|
NCBI chr X:63,268,106...63,291,125
Ensembl chr X:63,268,037...63,292,092
|
|
|
G |
Acss2 |
acyl-CoA synthetase short-chain family member 2 |
treatment |
ISO |
|
RGD |
PMID:22384010 |
RGD:13831306 |
NCBI chr 3:151,032,925...151,075,856
Ensembl chr 3:151,032,952...151,075,856
|
|
G |
Adcy3 |
adenylate cyclase 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29311637 |
|
NCBI chr 6:28,570,941...28,648,848
Ensembl chr 6:28,571,351...28,650,148
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
treatment |
ISO |
|
RGD |
PMID:22828946 |
RGD:7243249 |
NCBI chr20:4,363,152...4,366,079
Ensembl chr20:4,363,152...4,366,079
|
|
G |
Apln |
apelin |
|
ISO |
associated with Diabetes Mellitus, Non-Insulin-Dependent protein:increased expression:plasma |
RGD |
PMID:19756893, PMID:15970339 |
RGD:2313938, RGD:1600932 |
NCBI chr X:134,856,719...134,866,210
Ensembl chr X:134,856,726...134,866,210
|
|
G |
Aqp7 |
aquaporin 7 |
|
ISO |
mRNA:decreased expression:subcutaneous adipose tissue |
RGD |
PMID:17566090 |
RGD:1626289 |
NCBI chr 5:57,358,297...57,372,332
Ensembl chr 5:57,358,327...57,372,239
|
|
G |
Bbs4 |
Bardet-Biedl syndrome 4 |
susceptibility |
ISO |
DNA:SNPs |
RGD |
PMID:17003356 |
RGD:1601311 |
NCBI chr 8:64,115,005...64,154,432
Ensembl chr 8:64,121,392...64,154,396
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21708048 |
|
NCBI chr 3:100,768,637...100,819,216
Ensembl chr 3:100,768,637...100,819,210
|
|
G |
Cck |
cholecystokinin |
|
ISO |
|
RGD |
PMID:17443025 |
RGD:1625798 |
NCBI chr 8:130,120,525...130,127,515
Ensembl chr 8:130,120,523...130,127,392
|
|
G |
Cpe |
carboxypeptidase E |
|
ISO |
mRNA:increased expression:visceral abdominal fat:significantly higher expression in visceral fat than subcutaneous fat of morbidly obese subjects |
RGD |
PMID:12530526 |
RGD:1626182 |
NCBI chr16:26,906,716...27,014,811
Ensembl chr16:26,906,716...27,014,813
|
|
G |
Ctnnbl1 |
catenin, beta like 1 |
susceptibility no_association |
ISO |
DNA:snps:introns:IVS7+3134G>T, IVS7-79A>G (rs6013029, rs6020846) (human) |
RGD |
PMID:19245693, PMID:19228371 |
RGD:9850251, RGD:9850253 |
NCBI chr 3:154,212,245...154,373,170
Ensembl chr 3:154,212,202...154,373,169
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
ISO |
|
RGD |
PMID:12883487 |
RGD:1626305 |
NCBI chr 1:213,511,892...213,522,195
Ensembl chr 1:213,511,874...213,535,542
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
|
ISO |
|
RGD |
PMID:19188925 |
RGD:2313745 |
NCBI chr 4:145,674,157...145,678,066
Ensembl chr 4:145,674,157...145,678,066
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
|
ISO |
mRNA:increased expression:subcutaneous adipose tissue |
RGD |
PMID:16046292 |
RGD:1626320 |
NCBI chr 6:96,810,868...96,856,303
Ensembl chr 6:96,810,907...96,856,052
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:11889184 |
RGD:1626666 |
NCBI chr 3:1,449,778...1,468,624
Ensembl chr 3:1,452,644...1,468,614
|
|
G |
Kcnma1 |
potassium calcium-activated channel subfamily M alpha 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21708048 |
|
NCBI chr15:344,204...1,048,849
Ensembl chr15:344,360...1,047,956
|
|
G |
Ksr2 |
kinase suppressor of ras 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29273807 |
|
NCBI chr12:44,531,376...44,911,835
Ensembl chr12:44,536,293...44,911,147
|
|
G |
Lep |
leptin |
|
ISO |
CTD Direct Evidence: marker/mechanism|therapeutic |
CTD |
PMID:9500540 PMID:15070752 |
|
NCBI chr 4:56,337,695...56,351,818
Ensembl chr 4:56,337,695...56,351,818
|
|
G |
Lepr |
leptin receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: OBESITY, MORBID |
CTD ClinVar |
PMID:8666155 PMID:9537324 PMID:11354636 PMID:11443193 PMID:12006639 PMID:17785359 PMID:18490929 PMID:21393862 PMID:21744741 PMID:22331430 PMID:26467025 |
|
NCBI chr 5:120,503,475...120,682,281
Ensembl chr 5:120,564,645...120,682,221
|
|
G |
Lpin1 |
lipin 1 |
|
ISO |
|
RGD |
PMID:17563064 |
RGD:1641822 |
NCBI chr 6:41,796,214...41,905,149
Ensembl chr 6:41,799,749...41,870,046
|
|
G |
Mc4r |
melanocortin 4 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29273807 PMID:29311635, PMID:11443223, PMID:12588803 |
RGD:1600755, RGD:1600750 |
NCBI chr18:62,612,838...62,614,725
Ensembl chr18:62,612,838...62,614,725
|
|
G |
Mchr1 |
melanin-concentrating hormone receptor 1 |
onset |
ISO |
DNA:SNP:promoter |
RGD |
PMID:16186414 |
RGD:1624359 |
NCBI chr 7:122,456,846...122,459,324
Ensembl chr 7:122,456,799...122,459,960
|
|
G |
Nppb |
natriuretic peptide B |
|
ISO |
protein:increased expression:serum |
RGD |
PMID:17273651 |
RGD:1642195 |
NCBI chr 5:164,796,176...164,797,538
Ensembl chr 5:164,796,185...164,797,531
|
|
G |
Npy2r |
neuropeptide Y receptor Y2 |
|
ISO |
|
RGD |
PMID:15855352 |
RGD:1642381 |
NCBI chr 2:181,528,949...181,538,145
Ensembl chr 2:181,530,832...181,531,978
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
onset |
ISO |
|
RGD |
PMID:16702999 |
RGD:1626135 |
NCBI chr17:5,934,651...6,245,778
Ensembl chr17:5,933,729...6,244,676
|
|
G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
|
ISO |
|
RGD |
PMID:11874690 |
RGD:1357926 |
NCBI chr 2:91,450,162...91,497,091
Ensembl chr 2:91,450,162...91,497,091
|
|
G |
Pomc |
proopiomelanocortin |
|
ISO |
|
RGD |
PMID:11874690 |
RGD:1357926 |
NCBI chr 6:28,382,937...28,388,771
Ensembl chr 6:28,382,962...28,388,967
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
ISO |
ClinVar Annotator: match by term: OBESITY, SEVERE, UMLS MESH term: Severe Obesity |
ClinVar |
PMID:9753710 PMID:10690291 |
|
NCBI chr 4:147,274,055...147,399,383
Ensembl chr 4:147,274,107...147,399,380
|
|
G |
Ucp3 |
uncoupling protein 3 |
|
ISO |
ClinVar Annotator: match by term: OBESITY, SEVERE |
ClinVar |
PMID:9769326 PMID:28492532 |
|
NCBI chr 1:165,482,912...165,495,895
Ensembl chr 1:165,482,155...165,496,206
|
|
|
G |
Cep19 |
centrosomal protein 19 |
|
ISO |
ClinVar Annotator: match by term: Morbid obesity and spermatogenic failure |
OMIM ClinVar |
PMID:24268657 PMID:28492532 |
|
NCBI chr11:71,921,713...71,938,335
Ensembl chr11:71,921,716...71,938,165
|
|
|
G |
Inpp5e |
inositol polyphosphate-5-phosphatase E |
|
ISO |
DNA:nonsense mutation:exon:p.Q627X (c.1879C>T) (human) ClinVar Annotator: match by OMIM:610156 |
OMIM ClinVar |
PMID:19668215, PMID:19668215 |
RGD:12911209 |
NCBI chr 3:3,843,307...3,856,154
Ensembl chr 3:3,843,307...3,855,981
|
|
|
G |
Ntrk2 |
neurotrophic receptor tyrosine kinase 2 |
|
ISO |
ClinVar Annotator: match by term: Obesity, hyperphagia, and developmental delay |
OMIM ClinVar |
PMID:15494731 PMID:25741868 PMID:27884935 PMID:29100083 |
|
NCBI chr17:5,934,651...6,245,778
Ensembl chr17:5,933,729...6,244,676
|
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25137265 |
|
NCBI chr 8:50,525,091...50,526,875
Ensembl chr 8:50,525,091...50,526,875
|
|
G |
Apoa5 |
apolipoprotein A5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25137265 |
|
NCBI chr 8:50,559,079...50,561,720
Ensembl chr 8:50,559,126...50,561,736
|
|
G |
Fto |
FTO, alpha-ketoglutarate dependent dioxygenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25137265 |
|
NCBI chr19:16,774,549...17,115,098
Ensembl chr19:16,772,744...17,115,113
|
|
|
G |
Atp10a |
ATPase phospholipid transporting 10A (putative) |
|
ISO |
ClinVar Annotator: match by term: Prader-Willi syndrome |
ClinVar |
PMID:28631899 |
|
NCBI chr 1:115,973,343...116,141,892
Ensembl chr 1:115,975,324...116,141,892
|
|
G |
Gabra5 |
gamma-aminobutyric acid type A receptor subunit alpha 5 |
|
ISO |
ClinVar Annotator: match by term: Prader-Willi syndrome |
ClinVar |
PMID:28631899 |
|
NCBI chr 1:112,833,941...112,947,482
Ensembl chr 1:112,833,944...112,947,451
|
|
G |
Gabrb3 |
gamma-aminobutyric acid type A receptor subunit beta 3 |
|
ISO |
ClinVar Annotator: match by term: Prader-Willi syndrome |
ClinVar |
PMID:28631899 |
|
NCBI chr 1:113,034,251...113,265,364
Ensembl chr 1:112,976,770...113,265,364
|
|
G |
Gabrg3 |
gamma-aminobutyric acid type A receptor subunit gamma 3 |
|
ISO |
ClinVar Annotator: match by term: Prader-Willi syndrome |
ClinVar |
PMID:28631899 |
|
NCBI chr 1:112,158,525...112,812,267
Ensembl chr 1:112,158,519...112,811,936
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
|
ISO |
|
RGD |
PMID:15788704, PMID:15057669 |
RGD:1642818, RGD:12905043 |
NCBI chr 4:145,674,157...145,678,066
Ensembl chr 4:145,674,157...145,678,066
|
|
G |
Hcrt |
hypocretin neuropeptide precursor |
|
ISO |
|
RGD |
PMID:15613151 |
RGD:1600935 |
NCBI chr10:88,669,216...88,670,430
Ensembl chr10:88,669,214...88,670,430
|
|
G |
Herc2 |
HECT and RLD domain containing E3 ubiquitin protein ligase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Prader-Willi syndrome |
CTD ClinVar |
PMID:25741868 PMID:28631899 |
|
NCBI chr 1:114,453,033...114,653,787
Ensembl chr 1:114,453,054...114,653,793
|
|
G |
Htr2c |
5-hydroxytryptamine receptor 2C |
|
ISS |
OMIM:176270 |
MouseDO |
|
|
NCBI chr X:118,084,520...118,318,040
Ensembl chr X:118,084,890...118,318,039
|
|
G |
Magel2 |
MAGE family member L2 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Prader-Willi syndrome |
CTD ClinVar |
PMID:24076603 PMID:25741868 PMID:27195816 PMID:28281571 PMID:28492532 PMID:28631899 |
|
NCBI chr 1:123,015,404...123,019,945
Ensembl chr 1:123,015,746...123,019,522
|
|
G |
Mkrn3 |
makorin, ring finger protein, 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Prader-Willi syndrome |
CTD ClinVar |
PMID:28631899 |
|
NCBI chr 1:123,062,049...123,064,763
Ensembl chr 1:123,062,863...123,064,642
|
|
G |
Ndn |
necdin, MAGE family member |
|
ISO |
ClinVar Annotator: match by term: Prader-Willi syndrome |
ClinVar OMIM |
PMID:25741868 PMID:28631899, PMID:9630521 |
RGD:1601480 |
NCBI chr 1:122,981,755...122,983,354
Ensembl chr 1:122,981,755...122,983,351
|
|
G |
Oca2 |
OCA2 melanosomal transmembrane protein |
|
ISO |
ClinVar Annotator: match by term: Prader-Willi syndrome |
ClinVar |
PMID:28631899 |
|
NCBI chr 1:114,661,970...114,987,433
Ensembl chr 1:114,679,537...114,987,433
|
|
G |
Snrpn |
small nuclear ribonucleoprotein polypeptide N |
susceptibility |
ISO |
DNA:deletion ClinVar Annotator: match by term: Prader-Willi syndrome |
ClinVar OMIM |
PMID:28631899, PMID:8723064 |
RGD:1601354 |
NCBI chr 1:195,074,328...195,096,460
Ensembl chr 1:195,074,330...195,096,460
|
|
G |
Snurf |
SNRPN upstream reading frame |
|
ISO |
ClinVar Annotator: match by term: Prader-Willi syndrome |
ClinVar |
PMID:28631899 |
|
NCBI chr 1:195,074,328...195,096,694
Ensembl chr 1:195,074,330...195,096,694
|
|
G |
Ube3a |
ubiquitin protein ligase E3A |
|
ISO |
ClinVar Annotator: match by term: Prader-Willi syndrome |
ClinVar |
PMID:28631899 |
|
NCBI chr 1:116,586,901...116,678,161
Ensembl chr 1:116,587,815...116,679,973
|
|
|
G |
Pomc |
proopiomelanocortin |
|
ISO |
ClinVar Annotator: match by term: Proopiomelanocortin deficiency ClinVar Annotator: match by OMIM:609734 |
OMIM ClinVar |
PMID:9620771 PMID:12165561 PMID:14557433 PMID:16459314 PMID:18091355 PMID:18697863 PMID:18765507 PMID:19221669 PMID:20349035 PMID:23293326 PMID:25741868 PMID:28492532 |
|
NCBI chr 6:28,382,937...28,388,771
Ensembl chr 6:28,382,962...28,388,967
|
|
|
G |
Pcsk1 |
proprotein convertase subtilisin/kexin type 1 |
|
ISO |
ClinVar Annotator: match by term: Proprotein convertase 1/3 deficiency ClinVar Annotator: match by OMIM:600955 |
OMIM ClinVar |
PMID:9207799 PMID:14617756 PMID:17595246 PMID:22210313 PMID:23383060 PMID:23562752 PMID:24041679 PMID:24135795 PMID:24932808 PMID:25741868 PMID:26786350 PMID:27187081 PMID:28377240 PMID:28492532 |
|
NCBI chr 2:91,450,162...91,497,091
Ensembl chr 2:91,450,162...91,497,091
|
|
|
G |
Ric3 |
RIC3 acetylcholine receptor chaperone |
|
ISO |
ClinVar Annotator: match by term: Retinal dystrophy and obesity |
ClinVar |
PMID:25741868 |
|
NCBI chr 1:173,629,218...173,682,226
Ensembl chr 1:173,630,761...173,682,226
|
|
G |
Tub |
TUB bipartite transcription factor |
|
ISO |
ClinVar Annotator: match by term: Retinal dystrophy and obesity |
OMIM ClinVar |
PMID:25741868 |
|
NCBI chr 1:173,550,929...173,629,550
Ensembl chr 1:173,607,101...173,625,550
|
|
|
G |
Cyfip1 |
cytoplasmic FMR1 interacting protein 1 |
|
ISO |
associated with Fragile X Syndrome;mRNA:decreased expression:leukocyte (human) |
RGD |
PMID:17435464 |
RGD:11558012 |
NCBI chr 1:114,258,773...114,347,138
Ensembl chr 1:114,258,719...114,347,137
|
|
G |
Magel2 |
MAGE family member L2 |
|
ISO |
ClinVar Annotator: match by term: Schaaf-Yang syndrome ClinVar Annotator: match by term: Schaaf-yang syndrome ClinVar Annotator: match by OMIM:615547 |
OMIM ClinVar |
PMID:24076603 PMID:24088041 PMID:25326635 PMID:25473036 PMID:25741868 PMID:26365340 PMID:26633545 PMID:27195816 PMID:28281571 PMID:29581464 PMID:29599419 PMID:31397880 PMID:31680349 PMID:32860008 |
|
NCBI chr 1:123,015,404...123,019,945
Ensembl chr 1:123,015,746...123,019,522
|
|
G |
Sim1 |
SIM bHLH transcription factor 1 |
|
ISO |
ClinVar Annotator: match by term: Schaaf-yang syndrome |
ClinVar |
|
|
NCBI chr20:55,590,810...55,674,002
Ensembl chr20:55,594,676...55,673,995
|
|
|
G |
Kidins220 |
kinase D-interacting substrate 220 |
|
ISO |
ClinVar Annotator: match by term: SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY ClinVar Annotator: match by term: Spastic paraplegia, intellectual disability, nystagmus, and obesity |
ClinVar OMIM |
PMID:25741868 PMID:27005418 |
|
NCBI chr 6:44,225,14 | |